Reason;File;Name;Auth;Year;;
Anton;velentzis2017.pdf;How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country;Louiza S Velentzis, Michael Caruana, Kate T Simms, Jie-Bin Lew, Ju-Fang Shi, Marion Saville, Megan A Smith, Sarah J Lord, Jeffrey Tan, Deborah Bateson, Michael Quinn, Karen Canfell;2017;;
Anton;Draisma2009.pdf;lead time and overdiagnosis in prostate-specific antigen screening importance of methods and context;Gerrit Draisma , Ruth Etzioni , Alex Tsodikov , Angela Mariotto , Elisabeth Wever , Roman Gulati , Eric Feuer ,Harry de Koning;2009;;
Anton;Campos2016.pdf;cost-effectiveness of an hpv self-collection campaign in uganda comparing models for delivery of cervical cancer screening in a low-income setting;Nicole G Campos, Vivien Tsu, Jose Jeronimo, Denise Njama-Meya, Mercy Mvundura and Jane J Kim;2016;;
Anton3;montz2001.pdf;impact of increasing papanicolaou test sensitivity and compliance a modeled cost and outcomes analysis;F. J. Montz, Fredric L. Farber, Robert E. Bristow, Terri Cornelison;2001;;
Anton;hsieh2002.pdf;assessing chronic disease progression using non-homogeneous exponential regression markov models an illustration using a selective breast cancer screening in taiwan;Hsin-Ju Hsieh, Tony Hsiu-Hsi Chen, Shu-Hui Chang;2002;;
Anton;feuer2002.pdf;modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates;Eric J Feuer, Angela Mariotto, Ray Merrill;2002;;
Anton;draisma2003.pdf;lead times and overdetection due to prostate-specific antigen screening estimates from the european randomized study of screening for prostate cancer;Gerrit Draisma, Rob Boer, Suzie J Otto, Ingrid W van der Cruijsen,Ronald A M Damhuis, Fritz H Schroder, Harry J de Koning;2003;;
Anton;yen2003.pdf;quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening;M-F Yena, L Tabar, B Vitak, RA Smithe, H-H Chenf, SW Duffy;2003;;
Anton;goldie2004.pdf;projected clinical benefits and cost-effectiveness of a human papillomavirus 1618 vaccine;Sue J Goldie, Michele Kohli, Daniel Grima, Milton C Weinstein,Thomas C Wright, F Xavier Bosch, Eduardo Franco;2004;;
Anton;pinsky2004.pdf;An Early- and Late-Stage Convolution Model for Disease Natural History;P F Pinsky;2004;; 
Anton;barratt2005.pdf;model of outcomes of screening mammography information to support informed choices;Alexandra Barratt, Kirsten Howard, Les Irwig, Glenn Salkeld, Nehmat Houssami;2005;;
Anton;manser2005.pdf;cost-effectiveness analysis of screening for lung cancer with low dose spiral ct computed tomography in the australian setting;Renee Manser, Andrew Dalton, Rob Carter, Graham Byrnes,Mark Elwood, Donald A Campbell;2005;;
Anton;haug2005.pdf;a simulation model for colorectal cancer screening potential of stool tests with various performance characteristics compared with screening colonoscopy;Ulrike Haug, Hermann Brenner;2005;;
Anton;siebert2005.pdf;the german cervical cancer screening model development and validation of a decision-analytic model for cervical cancer screening in germany;Uwe Siebert, Gaby Sroczynski, Peter Hillemanns, Jutta Engel,Roland Stabenow, Christa Stegmaier, Kerstin Voigt,Bernhard Gibis, Dieter Ho lzel, Sue J Goldie;2005;;
Anton;groenewoud2006.pdf;cost-effectiveness of different reading and referral strategies in mammography screening in the netherlands;J H Groenewoud, J D M Otten, J Fracheboud, G Draisma, B M van Ineveld, R Holland, A L M Verbeek, H J de Koning;2006;;
Anton;plevritis2006.pdf;a natural history model of stage progression applied to breast cancer;Sylvia K Plevritis, Peter Salzman, Bronislava M Sigal, Peter W Glynn;2006;;
Anton;stout2006.pdf;retrospective cost-effectiveness analysis of screening mammography;Natasha K Stout, Marjorie A Rosenberg, Amy Trentham-Dietz, Maureen A Smith,Stephen M Robinson, Dennis G Fryback;2006;;
Anton;blanks2008.pdf;the development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the english nhs cervical screening programme--is there an optimum level of detection of cin 1 and cin 2 lesions;R G Blanks;2008;;
Anton;weedonfekjr2008.pdf;breast cancer tumor growth estimated through mammography screening data;Harald Weedon-Fekjr, Bo H Lindqvist, Lars J Vatten, Odd O Aalen, Steinar Tretli,;2008;;
Anton;bergeron2008.pdf;cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in france;C Bergeron, N Largeron, R McAllister, P Mathevet, V Remy;2008;;
Anton;mcmahon2008.pdf;Adopting Helical CT Screening for Lung Cancer Potential Health Consequences During a 15-Year Period;Pamela M McMahon,Chung Yin Kong, Milton C Weinstein, Angela C Tramontano, Lauren E Cipriano, Bruce E Johnson, Jane C Weeks, G Scott Gazelle;2008;;
Anton;reynalesshigematsu2009.pdf;cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in mexico;Luz Myriam Reynales-Shigematsu, Eliane R Rodrigues, Eduardo Lazcano-Ponce;2009;;
Anton;anonychuk2009.pdf;a cost-utility analysis of cervical cancer vaccination in preadolescent canadian females;Andrea M Anonychuk, Chris T Bauch, Maraki Fikre Merid, Georges Van Kriekinge, Nadia Demarteau;2009;;
Anton;vijayaraghavan2009.pdf;cost-effectiveness of high-risk hpv dna testing for cervical cancer screening in south africa;Arthi Vijayaraghavan, Molly Efrusy, Gerhard Lindeque, Greta Dreyer, Christopher Santas;2009;;
Anton;goldwasser2009.pdf;modeling excess lung cancer risk among screened arm participants in the mayo lung project;Deborah L Goldwasser,Marek Kimmel, ;2009;;
Anton;yen2009.pdf;estimating the long-term clinical impact of cervical cancer vaccination in taiwan;Ming-Shien Yen, Shan-Lin You, Nicole Ferko, Donna Debicki, Yi-Chen Chen, Cheng-Yang Chou;2009;;
Anton;berg2009.pdf;a discrete event simulation model to evaluate operational performance of a colonoscopy suite;Bjorn Berg, Brian Denton,Heidi Nelson,Hari Balasubramanian,Ahmed Rahman, Angela Bailey, Keith Lindor;2009;;
Anton;wever2010.pdf;prostate-specific antigen screening in the united states vs in the european randomized study of screening for prostate cancer-rotterdam;Elisabeth M Wever, Gerrit Draisma, Eveline A M Heijnsdijk, Monique J Roobol, Rob Boer, Suzie J Otto, Harry J de Koning;2010;;
Anton;berkhof2010.pdf;the health and economic effects of hpv dna screening in the netherlands;Johannes Berkhof, Veerle M Coupe, Johannes A Bogaards, Folkert J van Kemenade,Theo J Helmerhorst, Peter J Snijders, Chris J Meijer;2010;;
Anton;jit2011.pdf;human papillomavirus vaccine introduction in low-income and middle-income countries guidance on the use of cost-effectiveness models;Mark Jit, Nadia Demarteau, Elamin Elbasha, Gary Ginsberg, Jane Kim, Naiyana Praditsitthikorn,Edina Sinanovic, Raymond Hutubessy;2011;;
Anton;chen2011.pdf;cost-effectiveness analysis for pap smear screening and human papillomavirus dna testing and vaccination;Meng-Kan Chen, Hui-Fang Hung, Stephen Duffy, Amy Ming-Fang Yen, Hsiu-Hsi Chen;2011;;
Anton;goldie2011.pdf;model-based analyses to compare health and economic outcomes of cancer control inclusion of disparities;Sue J Goldie, Norman Daniels;2011;;
Anton;draisma2013.pdf;a note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening;Gerrit Draisma, Joost van Rosmalena ;2013;;
Anton;edwards2010.pdf;annual report to the nation on the status of cancer 1975-2006 featuring colorectal cancer trends and impact of interventions risk factors screening and treatment to reduce future rates;Brenda K Edwards,Elizabeth Ward,Betsy A Kohler, Christie Eheman, Ann G Zauber,Robert N Anderson,Ahmedin Jemal, Maria J Schymura,Iris Lansdorp-Vogelaar, Laura C Seeff, Marjolein van Ballegooijen, S Luuk Goede, Lynn A G Ries;2009;;
Anton;dhar2018.pdf;Catalyzing Novel Approaches to Rapid, Accurate, and Affordable Early Cancer Detection;Asif Dhar, Beth Meagher, Andrew Ryscavage;2018;;
Anton;meza2014.pdf;comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the nlst and plco trials;Rafael Meza, Kevin ten Haaf, Chung Yin Kong, Ayca Erdogan, William C Black, Martin C Tammemagi, Sung Eun Choi, Jihyoun Jeon, Summer S Han, Vidit Munshi,Joost van Rosmalen, Paul Pinsky, Pamela M McMahon, Harry J de Koning, Eric J Feuer, William D Hazelton, Sylvia K Plevritis ;2014;;
Anton;ladabaum2010.pdf;cost-effectiveness of colorectal cancer screening in high-risk spanish patients use of a validated model to inform public policy;Uri Ladabaum, Angel Ferrandez, Angel Lanas;2010;;
Anton;silvaillanes2018.pdf;critical analysis of markov models used for the economic evaluation of colorectal cancer screening a systematic review;Nicolas Silva-Illanes, Manuel Espinoza;2018;;
Anton;gunsoy2014.pdf;estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the united kingdom;N B Gunsoy, M Garcia-Closas, S M Moss;2014;;
Anton;westra2013.pdf;Inclusion of the benefits of enhanced cross protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands;Tjalke A Westra, Irina Stirbu-Wagner, Sara Dorsman, Eric D Tutuhatunewa, Edwin L de Vrij, Hans W Nijman,Toos Daemen, Jan C Wilschut, Maarten J Postma;2013;;
Anton;Steen2015.pdf;Optimal Colorectal Cancer Screening in States? Low-Income, Uninsured Populations The Case of South Carolina;Alex van der Steen, Amy B Knudsen, Frank van Hees,Gailya P Walter, Franklin G Berger, Virginie G Daguise,Karen M Kuntz, Ann G Zauber, Marjolein van Ballegooijen,Iris Lansdorp-Vogelaar;2015;;
Anton;kobayashi2007.pdf;prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective;T Kobayashi,R Goto, K Ito, K Mitsumori;2007;;
Anton;10.1002@ijc.31265.pdf;Quality of life assumptions determine which cervical cancer screening strategies are cost-effective;Inge MCM de Kok, Ida J Korfage,Wilbert B van den Hout,Theo JM Helmerhorst,J Dik F Habbema,Marie-Louise Essink-Bot,Marjolein van Ballegooijen,;2018;;
Anton;uuskla2013.pdf;The epidemiological and economic impact of aqua-drivalent human papillomavirus (hpv) vaccine in Estonia;Anneli Uuskla, Andres Mrsepp, Kosuke Kawai, Mait Raag, Mikk Jrisson, Matthew Pillsbury;2013;;
Anton;nihms115777.pdf;trade-offs in cervical cancer prevention balancing benefits and risks;Natasha K Stout, Jeremy D Goldhaber-Fiebert, Jesse D Ortendahl, Sue J Goldie ;2008;;
Anton;rutter2017.pdf;Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study;Carolyn M Rutter, Jane J Kim, Reinier GS Meester, Brian L Sprague,Emily A Burger, Ann G Zauber, Mehmet Ali Ergun, Nicole G Campos,Chyke A Doubeni, Amy Trentham-Dietz, Stephen Sy, Oguzhan Alagoz, Natasha Stout,Iris Lansdorp-Vogelaar, Douglas A Corley, Anna N A Tosteson;2017;;
Anton;gulati2012.pdf;the impact of plco control arm contamination on perceived psa screening efficacy;Roman Gulati, Alex Tsodikov, Elisabeth M Wever, Angela B Mariotto, Eveline A M Heijnsdijk, Jeffrey Katcher, Harry J de Koning, Ruth Etzioni;2012;;
Anton;schultz2012.pdf;chapter 7 description of miscan-lung the erasmus mc lung cancer microsimulation model for evaluating cancer control interventions;F W Schultz, R Boer, H J de Koning;2012;;
Anton;hanly2012.pdf;cost-effectiveness of computed tomography colonography in colorectal cancer screening a systematic review;Paul Hanly, Helen Fenlon, Mairead Skally,Linda Sharp;2012;;
Anton;gunsoy2012.pdf;Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40to 49 in the United Kingdom;Necdet B Gunsoy, Montserrat Garcia-Closas, Sue M Moss;2012;;
Anton;luttjeboer2013.pdf;cost-effectiveness of the prophylactic hpv vaccine an application to the netherlands taking non-cervical cancers and cross-protection into account;J Luttjeboer, TA Westra, JC Wilschut, HW Nijman, T Daemen, MJ Postma;2013;;
Anton;quentin2011.pdf;costs of cervical cancer screening and treatment using visual inspection with acetic acid via and cryotherapy in ghana the importance of scale;Wilm Quentin, Yaw Adu-Sarkodie, Fern Terris-Prestholt, Rosa Legood, Baafuor K Opoku,Philippe Mayaud;2011;;
Anton;vanagas2012.pdf;healthcare spending in the case of a hpv1618 population-wide vaccination programme;Giedrius Vanagas, Zilvinas Padaiga;2012;;
Anton;crowcroft2012.pdf;Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study;Natasha S Crowcroft, Jemila S Hamid, Shelley L Deeks, John Frank,;2012;;
Anton;uhry2010.pdf;multi-state markov models in cancer screening evaluation a brief review and case study;Z Uhry, G Hdelin, M Colonna, B Asselain, P Arveux, A Rogel, C Exbrayat, C Guldenfels, I Courtial, P Soler-Michel, F Molini, D Eilstein, SW Duffy;2010;;
Anton;navernik2014.pdf;output correlations in probabilistic models with multiple alternatives;Klemen Naversnik;2014;;
Anton;zelle2014.pdf;predicting the stage shift as a result of breast cancer screening in low- and middle-income countries a proof of concept;Sten G Zelle, Rob Baltussen, Johannes DM Otten,Eveline AM Heijnsdijk, Guido van Schoor, Mireille JM Broeders,;2014;;
Anton;armstrong2010.pdf;prophylaxis of cervical cancer and related cervical disease a review of the cost-effectiveness of vaccination against oncogenic hpv types;Edward P Armstrong;2010;;
Anton;wever2012.pdf;to be screened or not to be screened modeling the consequences of psa screening for the individual;EM Wever, J Hugosson, EAM Heijnsdijk, CH Bangma, G Draisma, HJ de Koning;2012;;
Anton;yeh2013.pdf;sorting it out pile sorting as a mixed methodology for exploring barriers to cancer screening;Hung-Wen Yeh, Byron J Gajewski, David G Perdue, Angel Cully, Lance Cully, K Allen Greiner, Won S Choi, Christine Makosy Daley;2013;;
Anton;petry2013.pdf;Annual Papanicolaou screening for 5 years among human papillomavirus-negative women;Karl Ulrich Petry, Franziska Rinnau, Gerd Bhmer, Bettina Hollwitz, Alexander Luyten, Nina Buttmann,Martin Brnger, Thomas Iftner;2013;;
Anton;witte2017.pdf;an em algorithm for nonparametric estimation of the cumulative incidence function from repeated imperfect test results;Birgit I Witte, Johannes Berkhof, Marianne A Jonker;2017;;
Anton;10.1093@jnci@djv103.pdf;benefits and harms of mammography screening after age 74 years model estimates of overdiagnosis;Nicolien T van Ravesteyn, Natasha K Stout, Clyde B Schechter,Eveline A M Heijnsdijk, Oguzhan Alagoz, Amy Trentham-Dietz,Jeanne S Mandelblatt, Harry J de Koning;2015;;
Anton;ekwunife2016.pdf;challenges in cost-effectiveness analysis modelling of hpv vaccines in low- and middle-income countries a systematic review and practice recommendations;Obinna I Ekwunife, James F OMahony, Andreas Gerber Grote,Christoph Mosch, Tatjana Paeck, Stefan K Lhachimi,;2016;;
Anton;10.1002@cncr.31141.pdf;comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance;Tiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning, ;2017;;
Anton;wu2006.pdf;cost-effectiveness analysis of colorectal cancer screening with stool dna testing in intermediate-incidence countries;Grace Hui-Min Wu, Yi-Ming Wang, Amy Ming-Fang Yen, Jau-Min Wong,Hsin-Chih Lai, Jane Warwick, Tony Hsiu-Hsi Chen,;2006;;
Anton;vok2012.pdf;cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary;Zoltan Voko, Laszlo Nagyjanosi, Zoltan Kalo;2012;;
Anton;romagnuolo2007.pdf;cost-effectiveness of Colorectal Cancer Screening With Computed Tomography Colonography The Impact of Not Reporting Diminutive Lesions;Joseph Romagnuolo;2007;;
Anton;chesson2008.pdf;cost-effectiveness of Human Papillomavirus Vaccination inthe United States;Harrell W Chesson, Donatus U Ekwueme, Mona Saraiya, Lauri E Markowitz;2008;;
Anton;berkhof2006.pdf;evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis;Johannes Berkhof, Martine C de Bruijne, Gilda D Zielinski, Nicole WJ Bulkmans, Lawrence Rozendaal,Peter JF Snijders, Rene HM Verheijen, Chris JLM Meijer;2006;;
Anton;duffy2005.pdf;overdiagnosis and overtreatment of breast cancer - estimates of overdiagnosis from two trials of mammographic screening for breast cancer;Stephen W Duffy, Olorunsola Agbaje, Laszlo Tabar, Bedrich Vitak, Nils Bjurstam,Lena Bjrneld, Jonathan P Myles, Jane Warwick;2005;;
Anton;olsen2006.pdf;overdiagnosis sojourn time and sensitivity in the copenhagen mammography screening program;Anne Helene Olsen, Olorunsola F Agbaje, Jonathan P Myles,Elsebeth Lynge,Stephen W Duffy;2006;;
Anton;10.1177@0969141316629505.pdf;The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer;Paula A van Luijt, Kirsten Rozemeijer, Steffie K Naber,Eveline AM Heijnsdijk, Joost van Rosmalen,Marjolein van Ballegooijen, Harry J de Koning;2016;;
Anton;jit2014.pdf;cost-effectiveness of female human papillomavirus vaccination in 179 countries a prime modelling study;Mark Jit, Marc Brisson, Allison Portnoy, Raymond Hutubessy;2014;;
Anton;huh2014.pdf;cost-effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening;Warner K Huh, Erin Williams, Joice Huang, Tommy Bramley, Nick Poulios;2014;;
Anton;duffy2014.pdf;translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the united kingdom;S W Duffy, J K Field, P C Allgood, A Seigneurin;2014;;
Anton;gulati2014.pdf;individualized estimates of overdiagnosis in screen-detected prostate cancer;Roman Gulati, Lurdes Y T Inoue, John L Gore, Jeffrey Katcher, Ruth Etzioni;2014;;
Anton;mcmahon2014.pdf;comparing benefits from many possible computed tomography lung cancer screening programs extrapolating from the national lung screening trial using comparative modeling;Pamela M McMahon, Rafael Meza, Sylvia K Plevritis, William C Black, C Martin Tammemagi,Ayca Erdogan, Kevin ten Haaf, William Hazelton, Theodore R Holford, Jihyoun Jeon,Lauren Clarke, Chung Yin Kong, Sung Eun Choi, Vidit N Munshi, Summer S Han,Joost van Rosmalen, Paul F Pinsky, Suresh Moolgavkar, Harry J de Koning, Eric J Feuer;2014;;
Anton;lansdorpvogelaar2012.pdf;contribution of screening and survival differences to racial disparities in colorectal cancer rates;Iris Lansdorp-Vogelaar, Karen M Kuntz, Amy B Knudsen, Marjolein van Ballegooijen,Ann G Zauber, Ahmedin Jemal;2012;;
Anton;neeser2007.pdf;cost-effectiveness analysis of a quality-controlled mammography screening program from the swiss statutory health-care perspective quantitative assessment of the most influential factors;Kurt Neeser, Thomas Szucs, Jean-Luc Bulliard, Gaudenz Bachmann,Wendelin Schramm;2007;;
Anton;ekwunife2017.pdf;cost-effectiveness of human papilloma virus hpv vaccination in nigeria a decision analysis using pragmatic parameter estimates for cost and programme coverage;Obinna I Ekwunife, Stefan K Lhachimi;2017;;
Anton;han2017 (1).pdf;evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model;Summer S Han, S Ayca Erdogan, Iakovos Toumazis, Ann Leung,Sylvia K Plevritis;2015;;
Anton;mennini2009.pdf;health and economic impact associated with a quadrivalent hpv vaccine in italy;FS Mennini, P Giorgi Rossi, F Palazzo, N Largeron,;2009;;
Anton;meester2017.pdf;Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer;Reinier GS Meester, Chyke A Doubeni, Ann G Zauber,Marjolein van Ballegooijen, Douglas A Corley, Iris Lansdorp-Vogelaar;2017;;
Anton;seigneurin2016.pdf;overdiagnosis and overtreatment associated with breast cancer mammography screening a simulation study with calibration to population-based data;Arnaud Seigneurin, Jose Labarere, Olivier Franois, Catherine Exbrayat,Maylis Dupouy, Marc Filippi, Marc Colonna;2016;;
Anton;seigneurin2015.pdf;overdiagnosis associated with breast cancer screening a simulation study to compare lead-time adjustment methods;Seigneurin A, Labarre J, Duffy SW, Colonna M;2015;;
Anton;lang2011.pdf;quality of life treatments and patients willingness to pay for a complete remission of cervical cancer in taiwan;HUI-CHU LANG, KOYIN CHANG, YUNG-HSIANG YING;2011;;
Anton;jansen2013.pdf;quantifying lead-time bias in risk factor studies of cancer through simulation;Rick J Jansen, Bruce H Alexander, Kristin E Anderson, Timothy R Church ;2013;;
Anton;campos2015.pdf;cervical cancer screening in low-resource settings a cost-effectiveness framework for valuing tradeoffs between test performance and program coverage;Nicole G Campos, Philip E Castle, Thomas C Wright Jr, Jane J Kim;2015;;
Anton;levin2015.pdf;an extended cost-effectiveness analysis of publicly financed hpv vaccination to prevent cervical cancer in china;Carol E Levin, Monisha Sharma, Zachary Olson, Stphane Verguet, Ju-Fang Shi,Shao-Ming Wang, You-Lin Qiao, Dean T Jamison, Jane J Kim;2015;;
Anton;sepp2015.pdf;age-related incidence of cervical cancer supports two aetiological components a population-based register study;K Seppa, J Pitkaniemi, N Malila, M Hakamaa;2015;;
Anton;ruile2015.pdf;screening for breast cancer with breast-ct in a prohta simulation;Georg Ruile, Anatoli Djanatliev, Christine Kriza,Florian Meier, Ines Leb,Willi A Kalender, Peter L Kolominsky-Rabas;2015;;
Anton;lansdorpvogelaar2015.pdf;state disparities in colorectal cancer rates contributions of risk factors screening and survival differences;Iris Lansdorp-Vogelaar, S Lucas Goede, Jiemin Ma, Wu Xiau-Cheng, Karen Pawlish, Marjolein van Ballegooijen, Ahmedin Jemal, ;2015;;
Anton;birnbaum2015.pdf;Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer;Jeanette K Birnbaum, Ziding Feng, Roman Gulati, Jing Fan, Yair Lotan, John T Wei, Ruth Etzioni;2015;;
Anton;kolevakolarova2018.pdf;a modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening;Rositsa G Koleva-Kolarova, Alicja M Daszczucka, Chris de Jonge,Mohd Kahlil Abu Hantash, Zhuozhao Z Zhan, Erik Jan Postema, Talitha L Feenstra,Ruud M Pijnappel, Marcel JW Greuter, Geertruida H de Bocka ;2018;;
Anton;mcleod2017.pdf;Colorectal cancer screening: How health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age-range to screen;Melissa McLeod,Giorgi Kvizhinadze,Matt Boyd,Jan Barendregt,Diana Sarfati,Nick Wilson,Tony Blakely;2017;;
Anton;kafadar2005.pdf;computational methods in medical decision making to screen or not to screen;Karen Kafadar, Philip C Prorok;2005;;
Anton;pataky2014 (1).pdf;cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density;Reka Pataky, Zahra Ismail, Andrew J Coldman, Mark Elwood,Karen Gelmon, Lindsay Hedden, Greg Hislop, Lisa Kan,Bonnie McCoy, Ivo A Olivotto, Stuart Peacock;2014;;
Anton;10.1093@jnci@94.3.193.pdf;cost-effectiveness of cervical cancer screening comparison of screening policies;M Elske van den Akker-van Marle, Marjolein van Ballegooijen,Gerrit J van Oortmarssen, Rob Boer, J Dik F Habbema;2002;;
Anton;10.2307@41995445.pdf;cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in quebec canada;Arthi Vijayaraghavan, Molly B Efrusy, Marie-Hlne Mayrand, Christopher CSantas, Patricia Goggin;2010;;
Anton;rogoza2009.pdf;cost-effectiveness of prophylactic vaccination against human papillomavirus 1618 for the prevention of cervical cancer adaptation of an existing cohort model to the situation in the netherlands;RM Rogoza, TAWestra, N Ferko, JJ Tamminga, MF Drummond,T Daemen, JC Wilschut, MJ Postma,;2009;;
Anton;pickhardt2008.pdf;is there sufficient mdct capacity to provide colorectal cancer screening with ct colonography for the us population;Perry J Pickhardt,Cesare Hassan,Andrea Laghi,David H Kim,Angelo Zullo,Franco Iafrate,Sergio Morini;2008;;
Anton;etzioni2002.pdf;overdiagnosis due to prostate-specific antigen screening lessons from us prostate cancer incidence trends;Ruth Etzioni, David F Penson, Julie M Legler, Dante di Tommaso, Rob Boer,Peter H Gann, Eric J Feuer;2002;;
Anton;stoykova2008.pdf;putting national institute for health and clinical excellence guidance into practice a cost minimization model of a national roll-out of liquid based cytology in england;Boyka Stoykova,Georgi Kuzmanov,Robin Dowie;2008;;
Anton;myers2000.pdf;setting the target for a better cervical screening test characteristics of a cost-effective test for cervical neoplasia screening;Evan R Myers, Douglas C Mccrory, Sujha Subramanian, Nancy Mccall, Kavita Nanda, Mhs,Santanu Datta, David B Matchar;2000;;
Anton;luttjeboer2016.pdf;threshold cost-effectiveness analysis for a therapeutic vaccine against hpv-1618-positive cervical intraepithelial neoplasia in the netherlands;Jos Luttjeboer, Didik Setiawan, Qi Cao, Toos CAHH Daemen, Maarten J Postma;2016;;
Anton;silva2016.pdf;comparison of markov models used for the economic evaluation of colorectal cancer screening a systematic review;NS Silva;2016;;
Anton;ladabaum2016.pdf;Comparative Effectiveness and cost-effectiveness of a Multi-target Stool DNA Test to Screen for Colorectal Neoplasia;Uri Ladabaum, Ajitha Mannalithara, ;2016;;
Anton;bertsimas2016.pdf;optimal healthcare decision making under multiple mathematical models application in prostate cancer screening;Dimitris Bertsimas, John Silberholz, Thomas Trikalinos;2016;;
Anton;smith2016.pdf;transitioning from cytology-based screening to hpv-based screening at longer intervals implications for resource use;Megan A Smith, Dorota Gertig, Michaela Hall, Kate Simms, Jie-Bin Lew, Michael Malloy,Marion Saville, Karen Canfell,;2016;;
Anton;carlsson2016.pdf;estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice a microsimulation screening analysis;Sigrid V Carlsson, Tiago M de Carvalho, Student Monique J Roobol, Jonas Hugosson, Anssi Auvinen, Maciej Kwiatkowski, Arnauld Villers, Marco Zappa, Vera Nelen, Alvaro Paez, James A Eastham, Hans Lilja,Harry J de Koning, Andrew J Vickers, Eveline A M Heijnsdijk ;2016;;
Anton;goldwasser2016.pdf;Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): Evidence from The Surveillance, Epidemiology, and End Results Program (SEER) and the National Lung Screening Trial (NLST).;Deborah L Goldwasser,;2016;;
Anton;liu2016.pdf;Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China;Yi-Jun Liu, Qian Zhang, Shang-Ying Hu, Fang-Hui Zhao;2016;;
Anton;posso2016.pdf;cost-effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme;Margarita Posso, Misericrdia Carles, Montserrat Ru, Teresa Puig,Xavier Bonfill;2016;;
Anton;huang2017.pdf;a bayesian simulation model for breast cancer screening incidence treatment and mortality;Xuelin Huang, Yisheng Li, Juhee Song, Donald A Berry ;2017;;
Noneg;carter2003.pdf;A computer model for the study of breast cancer;KJ Carter, F Castro, E Kessler, B Erickson;2003;;
q12;kulasingam2007.pdf;a cost-effectiveness analysis of adding a human papillomavirus vaccine to the australian national cervical cancer screening program;S Kulasingam, L Connelly, E Conway, JS Hocking, E Myers, DG Regan, D Roder, J Ross, G Wain;2007;;
q12;dee2009.pdf;a cost-utility analysis of adding a bivalent or quadrivalent hpv vaccine to the irish cervical screening programme;Anne Dee, Fenton Howell;2009;;
q12;guerrero2015.pdf;a cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the philippines;Guerrero AM, Genuino AJ, Santillan M, Praditsitthikorn N, Chantarastapornchit V, Teerawattananon Y, Alejandria M, Toral JA;2015;;
q12;villanti2013.pdf;a cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions;Andrea C Villanti, Yiding Jiang, David B Abrams, Bruce S Pyenson;2013;;
FromReview;khandker2000.pdf;A DECISION MODEL AND cost-effectiveness ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS;Rezaul K Khandker,Jane D Dulski,Jeffrey B Kilpatrick,Randall P Ellis,Janet B Mitchell, William B Baine;2000;;
Anton;akhavantabatabaei2016.pdf;a markov decision process model for cervical cancer screening policies in colombia;Akhavan-Tabatabaei R, Sanchez DM, Yeung TG;2016;;
FromReview;plevritis2001.pdf;A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening.;S Plevritis;2001;;
Noneg;caleffi2009.pdf;a model to optimize public health care and downstage breast cancer in limited-resource populations in southern brazil porto alegre breast health intervention cohort;Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B;2009;;
FromReview;shen2005.pdf;Robust modeling in screening studies: estimation of   sensitivity and preclinical sojourn time distribution;YU SHEN, maRVIN ZELEN;2005;;
Anton;goldie2003.pdf;a potential error in evaluating cancer screening a comparison of 2 approaches for modeling underlying disease progression;Goldie SJ, Kuntz KM;2003;;
Noneg;wu2009.pdf;a projection of benefits due to fecal occult blood test for colorectal cancer;Wu D, Erwin D, Rosner GL;2009;;
FromReview;hassan2010.pdf;A Resect and Discard Strategy Would Improve cost-effectiveness ofColorectal Cancer Screening;CESARE HASSAN, PERRY J PICKHARDT, DOUGLAS K REX;2010;;
FromReview;3001506.pdf;A review and critique of modelling in prioritising and designing screening programmes;;1506;;
Noneg;lejeune2003.pdf;A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer;Lejeune C, Arveux P, Dancourt V, Fagnani F, Bonithon-Kopp C, Faivre J;2003;;
FromReview;bailey2010.pdf;a simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years;Bailey Stephanie, Sigal Bronislava, Sylvia Plevritis;2010;;
Anton;palma2015.pdf;a system dynamics model of serum prostate-specific antigen screening for prostate cancer;Anton Palma, David Lounsbury, Nicolas Schlecht, Ilir Agalliu;2015;;
FromReview;kuntz2011.pdf;A Systematic Comparison of Microsimulation Models of Colorectal Cancer: The Role of Assumptions about Adenoma Progression;Karen M Kuntz, Iris Lansdorp-Vogelaar, Carolyn M Rutter,Amy B Knudsen, Marjolein van Ballegooijen,James E Savarino, Eric J Feuer, Ann G Zauber;2011;;
Anton;stollenwerk2012.pdf;accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation;Bjoern Stollenwerk, Afschin Gandjour, Markus Luengen, Uwe Siebert;2012;;
FromReview;balasubramanian2010.pdf;Accuracy and cost-effectiveness of Cervical Cancer Screening by High-Risk Human Papillomavirus DNA Testing of Self-Collected Vaginal Samples;Akhila Balasubramanian, Shalini L Kulasingam, Atar Baer,James P Hughes, Evan R Myers, Constance Mao,Nancy B Kiviat, Laura A Koutsky;2010;;
Noneg;chen2010.pdf;Estimating key parameters in periodic breast cancer screeningâ€”Applicationto the Canadian National Breast Screening Study data;Yinlu Chen, Guy Brock, Dongfeng Wu;2010;;
Anton;10.1109@42.932741.pdf;an artificial intelligent algorithm for tumor detection in screening mammogram;Zheng, Chan;2010;;
Noneg;arrospide2013.pdf;An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain;Arrospide A, Forn C, Ru M, Tor N, Mar J, Bar M;2013;;
FromReview;sherlawjohnson2004.pdf;An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme;C Sherlaw-Johnson, Z Philips;2004;;
Noneg;rutter2010.pdf;an evidence-based microsimulation model for colorectal cancer validation and application;CM Rutter, JE Savarino;2010;;
Noneg;chiu2010.pdf;analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening;Sherry Y-H Chiu, Nea Malila, Amy M-F Yen, Ahti Anttila, Matti Hakama, H-H Chen ;2010;;
Noneg;lee2016.pdf;annual combined mammography and tomosynthesis screening is it really cost-effective;Lee CI, Lee JM, Tosteson AN;2016;;
Anton;borrs1998.pdf;anticipating the consequences for the primary therapy of breast cancer after introducing screening - a more global picture for health care policy making;JM Borras, JA Espinas, PMM Beemsterboer,A Granados, HJ de Koning;1998;;
Anton;ijpr-14-635.pdf;applying a simple model of cost-effectiveness study of hpv vaccine for iran;Khatibi M, Rasekh HR;2015;;
Noneg;zai2014.pdf;applying operations research to optimize a novel population management system for cancer screening;Adrian H Zai, Seokjin Kim, Arnold Kamis, Ken Hung, Jeremiah G Ronquillo,Henry C Chueh, Steven J Atlas,;2013;;
q12;ladabaum2001.pdf;aspirin as an adjunct to screening for prevention of sporadic colorectal cancer a cost-effectiveness analysis;Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM;2001;;
Anton;andersson2017.pdf;assessment of lead-time bias in estimates of relative survival for breast cancer;Andersson TM, Rutherford MJ, Humphreys K;2017;;
q12;steens2012.pdf;association between human papillomavirus vaccine uptake and cervical cancer screening in the netherlands implications for future impact on prevention;Steens A, Wielders CC, Bogaards JA, Boshuizen HC, de Greeff SC, de Melker HE;2012;;
Anton;plevritis2018.pdf;association of screening and treatment with breast cancer mortality by molecular subtype in us women 2000-2012;Sylvia K Plevritis, Diego Munoz, Allison W Kurian, Natasha K Stout, Oguzhan Alagoz, Aimee M Near, Sandra J Lee, Jeroen J van den Broek, Xuelin Huang, Clyde B Schechter, Brian L Sprague, Juhee Song, Harry J de Koning, Amy Trentham-Dietz, Nicolien T van Ravesteyn, Ronald Gangnon, Young Chandler,Yisheng Li, Cong Xu, Mehmet Ali Ergun, Hui Huang, Donald A Berry, Jeanne S Mandelblatt;2018;;
Anton;lansdorpvogelaar2009.pdf;at what costs will screening with ct colonography be competitive a cost-effectiveness approach;Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Ann G Zauber, Rob Boer, Janneke Wilschut, J Dik F Habbema;2009;;
Noneg;armero2008.pdf;bayesian assessment of times to diagnosis in breast cancer screening; Carmen Armero, Antonio Lopez-Quilez, Rut Lopez-Sanchez;2008;;
FromReview;myles2003.pdf;Bayesian evaluation of breast cancer screening using data from two studies;Jonathan P Myles, Richard M Nixon, Stephen W Duy, Laszlo Tabar,Caroline Boggis, Gareth Evans, Andrew Shenton, Anthony Howell;2003;;
Noneg;hsu2017.pdf;bayesian negative-binomial-family-based multistate markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors;Chen-Yang Hsu, Ming-Fang Yen, Anssi Auvinen, Yueh-Hsia Chiu, Hsiu-Hsi Chen;2016;;
Anton;hsieh2013.pdf;bayesian spatial analysis for the evaluation of breast cancer detection methods;JEFF CHING-FU HSIEH, SUSANNA M CRAMB, JAMES M MCGREE,PETER D BAADE, NATHAN AM DUNN, KERRIE L MENGERSEN;2014;;
Noneg;mandelblatt2002.pdf;Benefits and costs of using HPV testing to screen for cervical cancer.;Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K;2002;;
Anton;sprague2015.pdf;Benefits, Harms, and cost-effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts;Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN;2015;;
Noneg;10.1177@0969141316668379.pdf;breast cancer incidence trends in norway and estimates of overdiagnosis;van Luijt PA, Heijnsdijk EA, van Ravesteyn NT, Hofvind S, de Koning HJ;2016;;
Noneg;vacek2011.pdf;breast cancer risk assessment in women aged 70 and older;Vacek PM, Skelly JM, Geller BM;2011;;
Noneg;timmers2013.pdf;breast cancer risk prediction model a nomogram based on common mammographic screening findings;Timmers JM, Verbeek AL, IntHout J, Pijnappel RM, Broeders MJ, den Heeten GJ;2013;;
FromReview;okonkwo2008.pdf;breast cancer screening policies in developing countries a cost-effectiveness analysis for india;Quirine Lamberts Okonkwo, Gerrit Draisma, Arno der Kinderen, Martin L Brown, Harry J de Koning;2008;;
Noneg;michaelson1999.pdf;Breast cancer: computer simulation method for estimating optimal intervals for screening.;J Michaelson, E Halpern, DB Kopans;1999;;
Noneg;arveux2003.pdf;building a model to determine the cost-effectiveness of breast cancer screening in france;Arveux P, Wait S, Schaffer P;2003;;
q12;carreras2012.pdf;can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in italy;Giulia Carreras, Giuseppe Gorini, Eugenio Paci;2012;;
Noneg;dolan2013.pdf;can streamlined multicriteria decision analysis be used to implement shared decision making for colorectal cancer screening;Dolan JG, Boohaker E, Allison J, Imperiale TF;2014;;
Anton;saini2013.pdf;can the adenoma detection rate reliably identify low-performing endoscopists results of a modeling study;Saini SD, Schoenfeld P, Vijan S;2013;;
FromReview;creighton2010.pdf;Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years;Prudence Creighton, Jie-Bin Lew, Mark Clements, Megan Smith, Kirsten Howard, Suzanne Dyer,Sarah Lord, Karen Canfell,;2010;;
Noneg;wang2018.pdf;Challenges and research opportunities for lung cancer screening in China;Zixing Wang, Yuyan Wang, Yao Huang, Fang Xue, Wei Han, Yaoda Hu, Lei Wang, Wei Songand Jingmei Jiang;2018;;
Anton;nihms408197.pdf;chapter 9 the mgh-hms lung cancer policy model tobacco control versus screening;McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS;2012;;
Noneg;10.1177@0272989x11408915.pdf;clarifying differences in natural history between models of screening the case of colorectal cancer;Marjolein van Ballegooijen, Carolyn M Rutter,Amy B Knudsen, Ann G Zauber, James E Savarino,Iris Lansdorp-Vogelaar, Rob Boer, Eric J Feuer,J Dik F Habbema, Karen M Kuntz;2012;;
Noneg;prakash2017.pdf;cmost an open-source framework for the microsimulation of colorectal cancer screening strategies;Meher K Prakash, Brian Lang, Henriette Heinrich, Piero V Valli, Peter Bauerfeind, Amnon Sonnenberg,Niko Beerenwinkel, Benjamin Misselwitz;2017;;
FromReview;hassan2007.pdf;Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy;C Hassan, A Zullo, A Laghi, I Reitano, F Taggi, P Cerro,F Iafrate, M Giustini, S Winn, S Morini,;2007;;
FromReview;nejmoa054967.pdf;Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia;;4967;;
FromReview;mandel1999.pdf;Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood;Jack S Mandel, Timothy R Church, Fred Ederer, John H Bond;1999;;
Anton;ladabaum2006.pdf;colorectal cancer screening - differential costs for younger versus older americans;U Ladabaum, KA Phillips, ;2006;;
Noneg;joseph2016.pdf;colorectal cancer screening estimated future colonoscopy need and current volume and capacity;Djenaba A Joseph, Reinier G S Meester, Ann G Zauber, Diane L Manninen, Linda Winges, Fred B Dong, Brandy Peaker, Marjolein van Ballegooijen;2016;;
Anton;wolf2018.pdf;colorectal cancer screening for average-risk adults 2018 guideline update from the american cancer society;Andrew M D Wolf, Elizabeth T H Fontham, DrPH Timothy R Church, Christopher R Flowers, Carmen E Guerra, Samuel J LaMonte, Ruth Etzioni, Matthew T McKenna, Kevin C Oeffinger, Ya-Chen Tina Shih, Louise C Walter, Kimberly S Andrews, BA Otis W Brawley, Durado Brooks, Stacey A Fedewa, Deana Manassaram-Baptiste, Rebecca L Siegel, Richard C Wender, Robert A Smith;2018;;
FromReview;heitman2010.pdf;Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation;Steven J Heitman, Robert J Hilsden, Flora Au, Scot Dowden, Braden J Manns;2010;;
Noneg;stone2004.pdf;colorectal cancer screening in australia an economic evaluation of a potential biennial screening program using faecal occult blood tests;Stone CA, Carter RC, Vos T, John JS;2004;;
Noneg;lee2007.pdf;colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer a prospective cohort study in japan;Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S Japan Public Health Center-based Prospective Study;2007;;
Noneg;10.1.1.557.8022.pdf;Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan;Kuo-Ching Yang, Chao-Sheng Liao, Yueh-Hsia Chiu, Amy Ming-Fang Yen, Tony Hsiu-Hsi Chen;2007;;
FromReview;gyrdhansen1998.pdf;COLORECTAL CANCER SCREENING:EFFICIENCY AND EFFECTIVENESS;Dorte Gyrd-Hansen, Jessogaard, Ole Kronborg;1998;;
FromReview;pence2012.pdf;Combination Aspirin and/or Calcium Chemoprevention with Colonoscopy in Colorectal Cancer Prevention: cost-effectiveness Analyses;Barbara C Pence, Eric J Belasco, Conrad P Lyford;2012;;
Anton;landy2017.pdf;What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study;Rebecca Landy, Peter Windridge, Matthew S Gillman, Peter D Sasieni;2018;;
FromReview;vickers2013.pdf;comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies model estimates of potential benefits and harms;Gulati R, Gore JL, Etzioni R;2013;;
Anton;trenthamdietz2017.pdf;Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening;Amy Trentham-Dietz, Mehmet Ali Ergun, Oguzhan Alagoz, Natasha K Stout, Ronald E Gangnon, John M Hampton, Kim Dittus, Ted A James, Pamela M Vacek, Sally D Herschorn, Elizabeth S Burnside, Anna N A Tosteson, Donald L Weaver, Brian L Sprague;2017;;
FromReview;ross2000.pdf;Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.;KS Ross, HB Carter, JD Pearson, HA Guess;2000;;
Noneg;10.1177@0272989x17718168.pdf;comparing cisnet breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49;Jeroen J van den Broek, Nicolien T van Ravesteyn, Jeanne S Mandelblatt,Hui Huang,Mehmet Ali Ergun, Elizabeth S Burnside, Cong Xu, Yisheng Li,Oguzhan Alagoz, Sandra J Lee, Natasha K Stout, Juhee Song, Amy Trentham-Dietz,Sylvia K Plevritis, Sue M Moss, Harry J de Koning;2017;;
q12;lin2011.pdf;comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model;Ray S Lin, Sylvia K Plevritis;2012;;
Noneg;kerlikowske1999.pdf;Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.;K Kerlikowske, P Salzmann, KA Phillips, JA Cauley, SR Cummings;1999;;
Noneg;bech2000.pdf;cost implications of routine mammography screening of women 50-69 years in the county of funen denmark;Bech M, Gyrd-Hansen D;2000;;
Noneg;lejeune2004.pdf;cost-effective analysis of fecal occult blood screening for colorectal cancer;Lejeune C, Arveux P, Dancourt V, Bejean S, Bonithon-Kopp C, Faivre J;2004;;
Noneg;manuel2004.pdf;cost-effectiveness analyses in gynecologic oncology methodological quality and trends;Manuel MR, Chen LM, Caughey AB, Subak LL;2004;;
FromReview;chen2007.pdf;cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16);Li-Sheng Chen, Chao-Sheng Liao, Shu-Hui Chang, Hsin-Chih Lai, Tony Hsiu-Hsi Chen;2007;;
Anton;szucs2008.pdf;cost-effectiveness analysis of adding a quadrivalent hpv vaccine to the cervical cancer screening programme in switzerland;Szucs TD, Largeron N, Dedes KJ, Rafia R, Benard S;2008;;
Noneg;cromwell2016.pdf;cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in british columbia canada;Cromwell I, Gaudet M, Peacock SJ, Aquino-Parsons C;2016;;
q12;mo2017.pdf;cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland china;Xiuting Mo, Ruoyan Gai Tobe, Lijie Wang, Xianchen Liu, Bin Wu, Huiwen Luo, Chie Nagata,Rintaro Mori, Takeo Nakayama;2017;;
Noneg;10.5888@pcd14.160158.pdf;cost-effectiveness analysis of four simulated colorectal cancer screening interventions north carolina;Kristen Hassmiller Lich, David A Cornejo Maria E Mayorga, Michael Pignone, Florence KL Tangka, Lisa C Richardson, Tzy-Mey Kuo, Anne-Marie Meyer,Ingrid J Hall, Judith Lee Smith, Todd A Durham, Steven A Chall, Trisha M Crutchfield, MHA, Stephanie B Wheeler,;2017;;
q12;obradovic2010.pdf;cost-effectiveness analysis of hpv vaccination alongside cervical cancer screening programme in slovenia;Obradovic M, Mrhar A, Kos M;2010;;
Noneg;hkm1006sp3p38.pdf;cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling;IOL Wong, KM Kuntz, BJ Cowling, CLK Lam, GM Leung;2010;;
Anton;konno2010.pdf;cost-effectiveness analysis of prophylactic cervical cancer vaccination in japanese women;Konno R, Sasagawa T, Fukuda T, Van Kriekinge G, Demarteau N;2010;;
Noneg;berchi2004.pdf;cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in france;Berchi C, Bouvier V, Reaud JM, Launoy G;2004;;
Noneg;tsoi2008.pdf;cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in asia;K K F TSOI, S S M NG, M C M LEUNG, J J Y SUNG;2008;;
Noneg;arrospide2018.pdf;cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using miscan-colon microsimulation model;Arantzazu Arrospide, Isabel Idigoras, Javier Mar, Harry de Koning, Miriam van der Meulen,Myriam Soto-Gordoa, Jose Miguel Martinez-Llorente, Isabel Portillo, Eunate Arana-Arri, Oliver Ibarrondo, Iris Lansdorp-Vogelaar;2018;;
Noneg;pil2016.pdf;cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer;Pil L, Fobelets M, Putman K, Trybou J, Annemans L;2016;;
Anton;cleemput2009.pdf;cost-effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium;Irina Cleemput, Nancy Thiry;2009;;
Noneg;lucidarme2012.pdf;cost-effectiveness modeling of colorectal cancer computed tomography colonography vs colonoscopy or fecal occult blood tests;Lucidarme O, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A;2012;;
Anton;schillerfrhwirth2017.pdf;cost-effectiveness models in breast cancer screening in the general population a systematic review;Irmgard C Schiller-Fruethwirth, Beate Jahn, Marjan Arvandi, Uwe Siebert ;2017;;
FromReview;chuck2010.pdf;cost-effectiveness of 21 Alternative Cervical Cancer Screening Strategies;Anderson Chuck;2010;;
q12;sopina2011.pdf;cost-effectiveness of a cervical screening program with human papillomavirus vaccine;Sopina E, Ashton T;2011;;
Noneg;sonnenberg2002.pdf;cost-effectiveness of a single colonoscopy in screening for colorectal cancer;Sonnenberg A, Delco F;2002;;
Noneg;ahern2014.pdf;cost-effectiveness of alternative strategies for integrating mri into breast cancer screening for women at high risk;Ahern CH, Shih YC, Dong W, Parmigiani G, Shen Y;2014;;
Noneg;cronin2013.pdf;cost-effectiveness of an advance notification letter to increase colorectal cancer screening;Cronin Paula, Goodall Stephen, Lockett Trevor, OKeefe Christine, Norman Richard, Church Jody;2013;;
Anton;czw182.pdf;cost-effectiveness of an hpv self-collection campaign in uganda comparing models for delivery of cervical cancer screening in a low-income setting;Campos, Nicole G Tsu, Vivien Jeronimo, Jose Njama-Meya, Denise Mvundura, Mercy Kim, Jane J;w182;;
Noneg;gocgun2015.pdf;cost-effectiveness of breast cancer screening policies using simulation;Gocgun Y, Banjevic D, Taghipour S, Montgomery N, Harvey BJ, Jardine AK, Miller AB;2015;;
Noneg;10.1097@grf.0b013e3182823797.pdf;cost-effectiveness of cervical cancer prevention;KATHARINE M ESSELEN, SARAH FELDMAN, ;2013;;
Noneg;berkhof2013.pdf;cost-effectiveness of cervical cancer prevention in central and eastern europe and central asia;Johannes Berkhof, Johannes A Bogaards, Erhan Demirel, Mireia Diaz,Monisha Sharma, Jane J Kim;2013;;
q12;zimmermann2017.pdf;cost-effectiveness of cervical cancer screening and preventative cryotherapy at anHIV treatment clinic in Kenya;Zimmermann Marita R, Vodicka Elisabeth, Babigumira Joseph B, Okech Timothy, Mugo Nelly, Sakr Samah, Garrison Louis, Chung Michael;2017;;
Anton;burger2012.pdf;cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in norway;EA Burger, JD Ortendahl, S Sy, IS Kristiansen, JJ Kim;2012;;
Noneg;melnitchouk2018.pdf;cost-effectiveness of colorectal cancer screening in Ukraine;Nelya Melnitchouk, Djra I Soeteman, Jennifer S Davids, Adam Fields, Joshua Cohen, Farzad Noubary,Andrey Lukashenko, Olena O Kolesnik, Karen M Freund;2018;;
FromReview;knudsen2010.pdf;cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population;Amy B Knudsen, Iris Lansdorp-Vogelaar, Carolyn M Rutter, James E Savarino, Marjolein van Ballegooijen, Karen M Kuntz,Ann G Zauber;2010;;
Noneg;mcmahon2011.pdf;cost-effectiveness of computed tomography screening for lung cancer in the united states;Pamela M McMahon, Chung Yin Kong, Colleen Bouzan,Milton C Weinstein, Lauren E Cipriano, Angela C Tramontano, Bruce E Johnson, Jane C Weeks, G Scott Gazelle, ;2011;;
FromReview;Gamboa2008.pdf;cost-effectiveness of conventional cytology and hpv dna testing for cervical cancer screening in colombia;Oscar Andres-Gamboa,Liliana Chicaza, Mario Garca-Molina,Jorge Daz, Mauricio Gonzlez, Ral Murillo,Mnica Ballesteros, Ricardo Snchez;2008;;
Noneg;lee2010.pdf;cost-effectiveness of ct colonography for uk nhs colorectal cancer screening of asymptomatic adults aged 60-69 years;David Lee, Dominic Muston, Alison Sweet, Chris Cunningham, Andrew Slaterand, Kevin Lock;2010;;
Noneg;nahvijou2016.pdf;cost-effectiveness of different cervical screening strategies in islamic republic of iran a middle-income country with a low incidence rate of cervical cancer;Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehdel K;2016;;
Noneg;sankatsing2015.pdf;cost-effectiveness of digital mammography screening before the age of 50 in the netherlands;Sankatsing VD, Heijnsdijk EA, van Luijt PA, van Ravesteyn NT, Fracheboud J, de Koning HJ;2015;;
FromReview;glick1998.pdf;cost-effectiveness of Double-Contrast Barium Enema in Screening for Colorectal Cancer;Seth Glick, Judith L Wagner, C Daniel Johnson ;1998;;
Noneg;carles2011.pdf;cost-effectiveness of early detection of breast cancer in catalonia spain;Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, Romn R, Sala M, Maci F, Castells X, Rue M;2011;;
Noneg;ouakrim2014.pdf;cost-effectiveness of family history-based colorectal cancer screening in Australia;Driss A Ouakrim, Alex Boussioutas, Trevor Lockett, John L Hopper, Mark A Jenkins;2014;;
q12;diaz2010.pdf;cost-effectiveness of human papillomavirus vaccination and screening in spain;Diaz M, de Sanjose S, Ortendahl J, OShea M, Goldie SJ, Bosch FX, Kim JJ;2010;;
q12;thiry2009.pdf;cost-effectiveness of human papillomavirus vaccination in belgium do not forget about cervical cancer screening;Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I;2009;;
Noneg;sharma2016.pdf;cost-effectiveness of increasing cervical cancer screening coverage in the middle east an example from lebanon;Sharma M, Seoud M, Kim JJ;2016;;
Noneg;wong2007.pdf;cost-effectiveness of mammography screening for chinese women;Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM;2007;;
Anton;moore2009.pdf;cost-effectiveness of mri compared to mammography for breast cancer screening in a high risk population;Susan G Moore, Pareen J Shenoy, Laura Fanucchi, John W Tumeh, Christopher R Flowers;2009;;
FromReview;10.1016@j.ejca.2008.09.015.pdf;cost-effectiveness of opportunistic versus organised mammography screening in switzerland;Rianne de Gelder, Jean-Luc Bulliard, Chris de Wolf, Jacques Fracheboud,Gerrit Draisma, Doris Schopper, Harry J de Koning;2009;;
FromReview;kim2004.pdf;cost-effectiveness of organized versus opportunistic cervical cytology screening in hong kong;JJ Kim, GM Leung, PPS Woo, SJ Goldie;2004;;
FromReview;sroczynski2011.pdf;cost-effectiveness of primary hpv screening for cervical cancer in germany - a decision analysis;Sroczynski G, Schnell-Inderst P, Muhlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Kramer A, Siebert U;2011;;
Anton;torvinen2010.pdf;cost-effectiveness of prophylactic hpv 1618 vaccination in finland results from a modelling exercise;Torvinen S, Nieminen P, Lehtinen M, Paavonen J, Demarteau N, Hahl J;2010;;
Noneg;lejeune2010.pdf;cost-effectiveness of screening for colorectal cancer in france using a guaiac test versus an immunochemical test;Lejeune C, Dancourt V, Arveux P, Bonithon-Kopp C, Faivre J;2010;;
Noneg;provenzale2002.pdf;cost-effectiveness of screening the average-risk population for colorectal cancer;Dawn Provenzale;2002;;
Noneg;376.pdf;cost-effectiveness of shortening screening interval or extending age range of nhs breast screening programme computer simulation study;Rob Boer, Harry de Koning, Anthony Threlfall, Peter Warmerdam, Andrew Street, Ellis Friedman,Ciaran Woodman;1998;;
Anton;simms2016.pdf;cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in australia a comparative modelling analysis;Kate T Simms, Jean-Franois Laprise, Megan A Smith, Jie-Bin Lew, Michael Caruana, Marc Brisson, Karen Canfell;2016;;
FromReview;pharoah2013.pdf;cost-effectiveness of the NHS breast screening programme: life table model;Paul D P Pharoah, Bernadette Sewell, Deborah Fitzsimmons, Hayley S Bennett,Nora Pashayan;2013;;
Anton;10.1002@ijc.30513.pdf;cost-effectiveness of the Norwegian Breast cancer screening program.;P A van Luijt, E A M Heijnsdijk, H J de Koning;2017;;
Noneg;ijcp-09-01-5443.pdf;cost-effectiveness of three rounds of mammography breast cancer screening in iranian women;Haghighat Shahpar, Akbari Mohammad Esmaeil, Yavari Parvin, Javanbakht Mehdi, Ghaffari Shahram;2016;;
Noneg;nihms307273.pdf;costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in australia;Michael P Pignone, Kathy L Flitcroft, Kirsten Howard, Lyndal J Trevena, Glenn P Salkeld, D James B St John,;2011;;
Noneg;zelle2012.pdf;costs effects and cost-effectiveness of breast cancer control in ghana;Zelle SG, Nyarko KM, Bosu WK, Aikins M, Nins LM, Lauer JA, Sepulveda CR, Hontelez JA, Baltussen R;2012;;
Noneg;whynes2003.pdf;costs of flexible sigmoidoscopy screening for colorectal cancer in the united kingdom;Whynes DK, Frew EJ, Edwards R, Atkin WS;2003;;
Noneg;karnon2008.pdf;cost-utility analysis of screening high-risk groups for anal cancer;Karnon Jonathan, Jones Roy, Czoski-Murray Carolyn, Srnith Kevin J;2008;;
FromReview;ness2000.pdf;Cost-Utility of One-Time Colonoscopic Screening for Colorectal Cancer at Various Ages;Reid M Ness, Ann M Holmes, Robert Klein, Robert Dittus;2000;;
Anton;silvaillanes2018.pdf;critical analysis of markov models used for the economic evaluation of colorectal cancer screening a systematic review;Silva-Illanes N, Espinoza M;2018;;
FromReview;cmaj_160_1_49.pdf;Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen;Murray D Krahn, B Ann Coombs, Isra G Levy;1999;;
Noneg;frame1998.pdf;determinants of cancer screening frequency the example of screening for cervical cancer;Paul S Frame, J Sutherland Frame;1998;;
Noneg;roberts2007.pdf;development of a simulation model of colorectal cancer;Roberts Stephen, Wang Lijun, Klein Robert, Ness Reid, Dittus Robert;2007;;
Noneg;10.1016@j.ypmed.2011.06.009.pdf;digital mammography screening weighing reduced mortality against increased overdiagnosis;Rianne de Gelder, Jacques Fracheboud, Eveline AM Heijnsdijk, Gerard den Heeten, Andre LM Verbeek, Mireille JM Broeders, Gerrit Draisma, Harry J de Koning;2011;;
Anton;boer2004.pdf;Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network(CISNET) Breast Cancer Groups;Boer R, Plevritis S, Clarke L;2004;;
Noneg;1328.full.pdf;do men and women need to be screened differently with fecal immunochemical testing a cost-effectiveness analysis;Miriam P van der Meulen, Atija Kapidzic, Monique E van Leerdam,Alex van der Steen, Ernst J Kuipers, Manon CW Spaander,Harry J de Koning, Lieke Hol, Iris Lansdorp-Vogelaar;2017;;
Noneg;armaroli2008.pdf;do women >50 years of age need as much screening as women <50 years after they have had negative screening results;Armaroli P, Gallo F, Bellomi A, Ciatto S, Consonni D, Davi D, Giorgi-Rossi P, Iossa A, Mancini E, Naldoni C, Polla E, Ronco G, Serafini M, Vergini V, Zanier L, Zappa M, Segnan N;2008;;
FromReview;beer2014.pdf;Does the HPV vaccination programme have implications for cervical screening programmes in the UK?;Helen Beer, Sam Hibbitts, Sinead Brophy, Rahman,Jo Waller, Shantini Paranjothy,;2014;;
q12;birnbaum2018.pdf;early detection and treatment strategies for breast cancer in low-income and upper middle-income countries a modelling study;Jeanette K Birnbaum, Catherine Duggan, Benjamin O Anderson, Ruth Etzioni;2018;;
Noneg;philips2001.pdf;early withdrawal from cervical cancer screening the question of cost-effectiveness;Philips, Z, Whynes, DK;2001;;
Noneg;10.1002@sici1099-1751199901@0314@157@@aid-hpm5313.0.co2-u.pdf;economic analysis of outreach assessment clinics in breast screening programmes;M M Van Der Pol, J A Cairns, F J Gilbert, P J Hendry;1999;;
FromReview;nghiem2015.pdf;Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening;V T Nghiem, K R Davies, J R Beck, M Follen, C MacAulay, M Guillaud, S B Cantor,;2015;;
Anton;brisson2009.pdf;economic evaluation of human papillomavirus vaccination in developed countries;Brisson M, Van de Velde N, Boily MC;2009;;
q12;praditsitthikorn2011.pdf;Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand;Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V;2011;;
FromReview;holmberg1998.pdf;Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden;Hakan Holmberg, Per Carlsson, Owe Lofman,Eberhard Varenhorst;1998;;
Anton;vanni2010.pdf;economic evaluation of strategies for managing women with equivocal cytological results in brazil;Vanni T, Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G;2010;;
Noneg;arrospide2016.pdf;economic evaluation of the breast cancer screening programme in the basque country retrospective cost-effectiveness and budget impact analysis;Arrospide A, Rue M, van Ravesteyn NT, Comas M, Soto-Gordoa M, Sarriugarte G, Mar J;2016;;
Noneg;medi-95-e3762.pdf;economic evaluation study cheer-compliant cost-effectiveness analysis of ras screening for treatment of metastatic colorectal cancer based on the calgb 80405 trial;Zhou Jing, Zhao Rongce, Wen Feng, Zhang Pengfei, Tang Ruilei, Chen Hongdou, Zhang Jian, Li Qiu;2016;;
Anton;vanni2012.pdf;economic modelling assessment of the hpv quadrivalent vaccine in brazil a dynamic individual-based approach;Vanni T, Luz PM, Foss A, Mesa-Frias M, Legood R;2012;;
Noneg;molins2009.pdf;effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme;E Molins, M Comas, R Roman, T Rodrguez-Blanco, M Sala,F Macia, C Murta-Nascimento, X Castells;2009;;
q12;158.full.pdf;effect of time to diagnostic testing for breast cervical and colorectal cancer screening abnormalities on screening efficacy a modeling study;Rutter Carolyn M, Kim Jane J, Meester Reinier G S, Sprague Brian L, Burger Emily A, Zauber Ann G, Ergun Mehmet Ali, Campos Nicole G, Doubeni Chyke A, Trentham-Dietz Amy, Sy Stephen, Alagoz Oguzhan, Stout Natasha, Lansdorp-Vogelaar Iris, Corley Douglas A, Tosteson Anna N A;2017;;
Noneg;agorastos2010.pdf;effect of type-specific human papillomavirus incidence on screening performance and cost;Theodoros Agorastos, Alexandros Sotiriadis, Christos J Emmanouilides;2010;;
Noneg;rue2009.pdf;effectiveness of early detection on breast cancer mortality reduction in catalonia spain;Rue M, Vilaprinyo E, Lee S, Martinez-Alonso M, Carles, Marcos-Gragera R, Pla R, Espinas JA;2009;;
Noneg;mandelblatt2009.pdf;effects of mammography screening under different screening schedules model estimates of potential benefits and harms;Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ Breast Cancer Working Group of the Cancer Intervention, Surveillance Modeling Network;2009;;
FromReview;munoz2014.pdf;Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality;Diego Munoz, Aimee M Near, Nicolien T van Ravesteyn, Sandra J Lee, Clyde B Schechter, Oguzhan Alagoz,Donald A Berry, Elizabeth S Burnside, Yaojen Chang, Gary Chisholm, Harry J de Koning, Mehmet Ali Ergun,Eveline A M Heijnsdijk, Hui Huang, Natasha K Stout, Brian L Sprague, Amy Trentham-Dietz, Jeanne S Mandelblatt, Sylvia K Plevritis;2014;;
Noneg;koong2007.pdf;efficacy and cost-effectiveness of nationwide cervical cancer screening in taiwan;MR McCredie, G Medley, KJ Sharples, RW Jones, J Baranyai, C Paul, DC Skegg;2007;;
Noneg;hassan2015.pdf;efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate;Hassan C, Rex DK, Zullo A, Kaminski MF;2015;;
Noneg;lai1998.pdf;efficacy of breast-cancer screening for female relatives of breast-cancer-index cases taiwan multicentre cancer screening tamcas;Mei-Shu LAI, Ming-Fang YEN, Hsu-Sung KUO, Shin-Lan KOONG, Tony Hsiu-Hsi CHEN, StephenW DUFFY;1998;;
FromReview;rodrguezmoranta2008.pdf;Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model;Francisco Rodrguez-Moranta, Marta Trapero-Bertran, Antoni Castells, Xavier Mas-Canal,Francesc Balaguer, Maria Pellis, Victria Gonzalo, Teresa Ocaa, Antoni Trilla, Josep M Piqu;2008;;
q12;hoerger2011.pdf;Estimated Effects of the National Breast and Cervical Cancer Early Detection Program on Breast Cancer Mortality;Hoerger TJ, Ekwueme DU, Miller JW, Uzunangelov V, Hall IJ, Segel J, Royalty J, Gardner JG, Smith JL, Li C;2011;;
Anton;munoz2018.pdf;estimating breast cancer survival by molecular subtype in the absence of screening and adjuvant treatment;Diego F Munoz, Sylvia K Plevritis;2018;;
Anton;zhang2016.pdf;estimating long-term clinical effectiveness and cost-effectiveness of hpv 1618 vaccine in china;Zhang Q, Liu YJ, Hu SY, Zhao FH;2016;;
Anton;weedonfekjaer2008.pdf;estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening;Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S;2008;;
Noneg;weedonfekjaer2010.pdf;Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening;Weedon-Fekjaer H, Tretli S, Aalen OO;2010;;
FromReview;prevost1998.pdf;Estimating Sensitivity and Sojourn Time in Screening for Colorectal Cancer A Comparison of Statistical Approaches;T C Prevost, G Launoy, S W Duffy, H H Chen;1998;;
Noneg;mvundura2014.pdf;estimating the costs of cervical cancer screening in high-burden sub-saharan african countries;Mvundura M, Tsu V;2014;;
Noneg;bending2010.pdf;estimating the direct costs of bowel cancer services provided by the national health service in england;Bending MW, Trueman P, Lowson KV, Pilgrim H, Tappenden P, Chilcott J, Tappenden J;2010;;
Anton;10.1002@ijc.29976.pdf;estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older 65 men;Tiago M de Carvalho, Eveline AM Heijnsdijk, Harry J de Koning;2015;;
Anton;kohli2006.pdf;estimating the long-term impact of a prophylactic human papillomavirus 1618 vaccine on the burden of cervical cancer in the uk;Kohli M, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M;2006;;
FromReview;pinsky2001.pdf;Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing;Paul F Pinsky;2001;;
Noneg;chang2007.pdf;estimation and prediction system for multi-state disease process application to analysis of organized screening regime;Chi-Ming Chang,Wen-Chou Lin,Hsu-Sung Kuo,Ming-Fang Yen, Tony Hsiu-Hsi Chen ;2007;;
FromReview;chien2008.pdf;estimation of mean sojourn time for lung cancer by chest x-ray screening with a bayesian approach;Chun-Ru Chien, Mei-Shu Lai, Tony Hsiu-Hsi Chen;2008;;
Noneg;wu2010.pdf;estimation of natural history parameters of breast cancer based on non-randomized organized screening data subsidiary analysis of effects of inter-screening interval sensitivity and attendance rate on reduction of advanced cancer;Jenny Chia-Yun Wu, Matti Hakama, Ahti Anttila, Amy Ming-Fang Yen, Nea Malila, Tytti Sarkeala, Anssi Auvinen, Sherry Yueh-Hsia Chiu, Hsiu-Hsi Chen;2010;;
Anton;kim2012.pdf;estimation of sensitivity depending on sojourn time and time spent in preclinical state;Kim S, Wu D;2014;;
Anton;westvik2018.pdf;evaluating different breast tumor progression models using screening data;Asbjorn Schumacher Westvik, Harald Weedon-Fekjaer, Jan Maehlen, Knut Liestol;2018;;
Noneg;sheehan2017.pdf;evaluating lung cancer screening in china implications for eligibility criteria design from a microsimulation modeling approach;Sheehan DF, Criss SD, Gazelle GS, Pandharipande PV, Kong CY,;2017;;
Noneg;baker1998.pdf;evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings;Stuart G Baker;1998;;
Noneg;tramontano2016.pdf;evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the usa a simulation modelling study;Tramontano AC, Sheehan DF, McMahon PM, Dowling EC, Holford TR, Ryczak K, Lesko SM, Levy DT, Kong CY;2016;;
Noneg;chen1998.pdf;evaluation by markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in sweden;H H Chen, E Thurfjell, S W Duffy, L Tabar;1998;;
Anton;gray2017.pdf;evaluation of a stratified national breast screening program in the united kingdom an early model-based cost-effectiveness analysis;Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne;2017;;
Noneg;2043.full.pdf;evaluation of breast cancer risk assessment techniques a cost-effectiveness analysis;Elissa M Ozanne, Laura J Esserman;2004;;
Noneg;arrospide2015.pdf;evaluation of health benefits and harms of the breast cancer screening programme in the basque country using discrete event simulation;Arrospide A, Rue M, van Ravesteyn NT, Comas M, Larraaga N, Sarriugarte G, Mar J,;2015;;
Noneg;lew2018.pdf;Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia;Jie-Bin Lew, D James B St John, Finlay A Macrae, Jon D Emery, Hooi C Ee, Mark A Jenkins, Emily He, Paul Grogan, Michael Caruana, Diana Sarfati, Marjolein JE Greuter, Veerle MH Coup, Karen Canfell;2018;;
Noneg;idigoras2018.pdf;evaluation of the colorectal cancer screening programme in the basque country spain and its effectiveness based on the miscan-colon model;I Idigoras, A Arrospide, I Portillo, E Arana-Arri, L Martnez-Indart, J Mar, H J de Koning, R Lastra,M Soto-Gordoa, M van der Meulen, I Lansdorp-Vogelaar;2017;;
q12;10.1.1.552.8587.pdf;evolution of multiple disease screening in keelung a model for community involvement in health interventions;Wang PE, Wang TT, Chiu YH, Yen AM, Chen TH;2006;;
Noneg;oncotarget-07-48168.pdf;expected long-term impact of screening endoscopy on colorectal cancer incidence a modelling study;Brenner Hermann, Kretschmann Jens, Stock Christian, Hoffmeister Michael;2016;;
Noneg;brenner2015.pdf;expected long-term impact of the german screening colonoscopy programme on colorectal cancer prevention analyses based on 4407971 screening colonoscopies;Brenner Hermann, Altenhofen Lutz, Stock Christian, Hoffmeister Michael;2015;;
Noneg;lew2012.pdf;Expenditure and resource utilisation for cervical screening in Australia;Jie-Bin Lew, Kirsten Howard, Dorota Gertig, Megan Smith, Mark Clements, Carolyn Nickson, Ju-Fang Shi,Suzanne Dyer, Sarah Lord, Prudence Creighton, Yoon-Jung Kang, Jeffrey Tan, Karen Canfell;2012;;
Noneg;duffy2010.pdf;Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme;Duffy SW, Sasieni P, Olsen AH, Cafferty FH;2010;;
Noneg;duarte2017.pdf;Exploring risk factors in breast cancer screening program data using structured geoadditive models with high order interaction;Elisa Duarte, Bruno de Sousa, Carmen Cadarso-Surez, Thomas Kneib,Vtor Rodrigues;2017;;
Anton;kim2008.pdf;Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy;Kim JJ, Kobus KE, Diaz M, OShea M, Van Minh H, Goldie SJ;2008;;
Anton;shi2011.pdf;exploring the uncertainties of early detection results model-based interpretation of mayo lung project;Lu Shi, Haijun Tian, William J McCarthy, Barbara Berman, Shinyi Wu, Rob Boer;2011;;
Noneg;russell2011.pdf;exploring the unknown and the unknowable with simulation models;Louise B Russell;2011;;
Noneg;whynes1998.pdf;faecal occult blood screening for colorectal cancer is it cost-effective;David K Whynes, Aileen R Neilson, Andrew R Walker, Jack D Hardcastle;1998;;
Noneg;fisher2010.pdf;faecal occult blood testing in areas of high incidence and mortality the effect of screening the population aged 50 to 59;Fisher R, Rooney PS;2010;;
Noneg;sharma2008.pdf;fecal occult blood testing best option for colorectal cancer screening in asia;Sharan Prakash Sharma;2008;;
q12;hkm1512sp6p9.pdf;generalised cost-effectiveness analysis for breast cancer prevention and care in hong kong chinese;IOL Wong, JWH Tsang, BJ Cowling, GM Leung;2015;;
Anton;draisma2006.pdf;gleason score age and screening modeling dedifferentiation in prostate cancer;Gerrit Draisma, Renske Postma, Fritz H Schroder, Theo H van der Kwast, Harry J de Koning;2006;;
FromReview;kearns2014.pdf;Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme;B Kearns, S Whyte, J Chilcott, J Patnick;2014;;
Noneg;goede2017.pdf;harms benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening;S Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G Zauber,Lawrence F Paszat, Jeffrey S Hoch, Jean H E Yong, Sonja Kroep, Jill Tinmouth,Iris Lansdorp-Vogelaar;2017;;
Noneg;krahn2013.pdf;health care costs for state transition models in prostate cancer;Murray D Krahn, Karen E Bremner, Brandon Zagorski,Shabbir M H Alibhai, Wendong Chen, George Tomlinson,Nicholas Mitsakakis, Gary Naglie ;2013;;
Anton;gomez2014.pdf;health economic analysis of human papillomavirus vaccines in women of chile perspective of the health care payer using a markov model;Gomez JA, Lepetic A, Demarteau N;2014;;
Noneg;howard2005.pdf;High participation rates are not necessary for cost-effective colorectal cancer screening;Howard K, Salkeld G, Irwig L, Adelstein BA;2005;;
q12;wever2011.pdf;how does early detection by screening affect disease progression modeling estimated benefits in prostate cancer screening;Wever EM, Draisma G, Heijnsdijk EA, de Koning HJ;2011;;
Anton;sasieni2009.pdf;how many cervical cancers are prevented by treatment of screen-detected disease in young women;Sasieni P, Castanon A, Parkin DM;2009;;
Noneg;wilschut2011.pdf;how much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer;Wilschut Janneke A, Steyerberg Ewout W, van Leerdam Monique E, Lansdorp-Vogelaar Iris, Habbema J Dik F, van Ballegooijen Marjolein;2011;;
Anton;nihms458845.pdf;how should individuals with a false-positive fecal occult blood test for colorectal cancer be managed a decision analysis;Haug U, Knudsen AB, Kuntz KM;2012;;
FromReview;coup2009.pdf;How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands;Veerle MH Coup, HE de Melker, Peter JF Snijders, Chris JLM Meijer, Johannes Berkhof;2009;;
Noneg;flores2010.pdf;hpv testing for cervical cancer screening appears more cost-effective than papanicolau cytology in mexico;Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernandez M, Granados-Garcia V, Perez R, Salmeron J;2011;;
Noneg;kulasingam2009.pdf;Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis;Shalini L Kulasingam, Raghu Rajan, Yvan St Pierre, C Victoria Atwood, Evan R Myers, Eduardo L Franco;2009;;
q12;janes2005.pdf;identifying target populations for screening or not screening using logic regression;Janes H, Pepe M, Kooperberg C, Newcomb P;2005;;
Anton;jacklyn2017.pdf;Impact of extending screening mammography to older women: information to support informed choices;Jacklyn Gemma, Howard Kirsten, Irwig Les, Houssami Nehmat, Hersch Jolyn, Barratt Alexandra;2017;;
Noneg;10.5694mja15.00912.pdf;impact of hpv sample self-collection for underscreened women in the renewed cervical screening program;Megan Smith, Jie Bin Lew, Kate Simms,Karen Canfell;2017;;
FromReview;etzioni2008.pdf;impact of psa screening on the incidence of advanced stage prostate cancer in the united states a surveillance modeling approach;Ruth Etzioni, Roman Gulati, Seth Falcon, David F Penson ;2008;;
Noneg;blanch2014.pdf;impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme;Blanch J, Sala M, Ibez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Ru M, Salas D;2014;;
Noneg;loeve2001.pdf;impact of systematic false-negative test results on the performance of faecal occult blood screening;F Loeve, R Boer, GJ van Oortmarssen, M van Ballegooijen, JDF Habbema;2001;;
Anton;ekwueme2014.pdf;Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Womenin the U.S., 1991?2007;Ekwueme DU, Uzunangelov VJ, Hoerger TJ, Miller JW, Saraiya M, Benard VB, Hall IJ, Royalty J, Li C, Myers ER;2014;;
Noneg;hassan2009.pdf;impact of whole-body ct screening on the cost-effectiveness of ct colonography;Hassan C, Pickhardt PJ, Laghi A, Zullo A, Kim DH, Iafrate F, Di Giulio L, Morini S;2009;;
Noneg;blanks2006.pdf;improving the nhs cervical screening laboratory performance indicators by making allowance for population age risk and screening interval;Blanks RG, Moss SM, Denton K;2006;;
Noneg;chauvin2011.pdf;incremental net benefit and acceptability of alternative health policies a case study of mass screening for colorectal cancer;Chauvin P, Josselin JM, Heresbach D;2011;;
Anton;castle2018.pdf;inefficiencies of over-screening and under-screening for cervical cancer prevention in the us;Philip E Castle, Cosette M Wheeler, Nicole G Campos, Stephen Sy, Emily A Burger, Jane J Kim ;2018;;
Noneg;berhane2003.pdf;Inference in Spline-Based Models for Multiple Time-to-Event Data, with Applications to a Breast Cancer Prevention Trial ;Berhane, K, Weissfeld, LA;2003;;
Noneg;jiang2015.pdf;inference on cancer screening exam accuracy using population-level administrative data;Jiang H, Brown PE, Walter SD;2015;;
Anton;10.1093@epirev@mxr009.pdf;interpreting overdiagnosis estimates in population-based mammography screening;de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ;2011;;
Noneg;lane2010.pdf;Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia;Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom J, Bampton PA, Cole SR;2010;;
q12;yamamoto2011.pdf;introducing hpv vaccine and scaling up screening procedures to prevent deaths from cervical cancer in japan a cost-effectiveness analysis;Yamamoto N, Mori R, Jacklin P, Osuga Y, Kawana K, Shibuya K, Taketani Y;2011;;
Noneg;alagoz2018.pdf;introduction to the cancer intervention and surveillance modeling network cisnet breast cancer models;Oguzhan Alagoz, Donald A Berry, Harry J de Koning, Eric J Feuer,Sandra J Lee, Sylvia K Plevritis, Clyde B Schechter, Natasha K Stout, Amy Trentham-Dietz, Jeanne S Mandelblatt,;2018;;
Noneg;hosking2013.pdf;investigating interventions for increasing colorectal cancer screening insights from a simulation model;Hosking Michael, Roberts Stephen, Uzsoy Reha, Joseph Talisa M;2013;;
Noneg;connor2000.pdf;investigation of design and bias issues in case-control studies of cancer screening using microsimulation;Robert J Connor, Rob Boer, Philip C Prorok, Douglas L Weed;2000;;
q12;accetta2010.pdf;is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women a cost-effectiveness analysis;Accetta G, Biggeri A, Carreras G, Lippi G, Carozzi FM, Confortini M, Zappa M, Paci E;2010;;
Anton;pataky2014.pdf;is prostate cancer screening cost-effective a microsimulation model of prostate-specific antigen-based screening for british columbia canada;Reka Pataky, Roman Gulati, Ruth Etzioni, Peter Black, Kim N Chi, Andrew J Coldman,Tom Pickles, Scott Tyldesley, Stuart Peacock,;2014;;
Noneg;park2013.pdf;korean risk assessment model for breast cancer risk prediction;Park B, Ma SH, Shin A, Chang M-C, Choi J-Y, Kim S, Han W, Noh D-Y, Ahn S-H, Kang D, Yoo K-Y, Park SK;2013;;
Anton;djp001.pdf;lead time and overdiagnosis in prostate-specific antigen screening importance of methods and context;Gerrit Draisma, Ruth Etzioni, Alex Tsodikov, Angela Mariotto, Elisabeth Wever, Roman Gulati, Eric Feuer, Harry de Koning ;2009;;
q12;lefevere2011.pdf;like mother like daughter mothers history of cervical cancer screening and daughters human papillomavirus vaccine uptake in flanders belgium;Lefevere E, Hens N, Theeten H, Van den Bosch K, Beutels P, De Smet F, Van Damme P ;2011;;
Anton;geurts2015.pdf;likely effect of adding flexible sigmoidoscopy to the english nhs bowel cancer screening programme impact on colorectal cancer cases and deaths;S M E Geurts, N J Massat, S W Duffy;2015;;
Anton;etzioni2013.pdf;limitations of basing screening policies on screening trials the us preventive services task force and prostate cancer screening;Ruth Etzioni, Roman Gulati, Matt R Cooperberg, David M Penson,Noel S Weiss, Ian M Thompson, ;2013;;
Anton;lew2017.pdf;Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study;Jie-Bin Lew, D James B St John, Xiang-Ming Xu, Marjolein J E Greuter, Michael Caruana, Dayna R Cenin, Emily He, Marion Saville, Paul Grogan,Veerle M H Coup, Karen Canfell;2017;;
Anton;hassan2012.pdf;loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists;Cesare Hassan, Douglas K Rex,Angelo Zullo, Gregory S Cooper;2012;;
FromReview;rijnsburger2004.pdf;MAMMOGRAPHY BENEFIT IN THE CANADIAN NATIONAL BREASTSCREENING STUDY-2: A MODEL EVALUATION;Adriana J Rijnsburger, Gerrit J Van Oortmarssen, Rob Boer, Gerrit Draisma, Teresa To, Anthony B Miller, Harry J De Koning;2004;;
FromReview;chien2008.pdf;Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach;Chun-Ru Chien, Mei-Shu Lai, Tony Hsiu-Hsi Chen;2008;;
Anton;gogov2016.pdf;Methodological features of prostate cancer screening models ? A review of simulation models;D Gogov, N Muhlberger, R Iskandar, Y Alimohammadi,U Siebert,;2016;;
Noneg;wilson2001.pdf;model of estimated rates of colorectal cancer from polyp growth by year of surveillance;Wilson LS, Lightwood J;2001;;
Noneg;monsonego2004.pdf;Screening 3 years after negative test, rather than annually, would result in three additional cases of cervical cancer per 100,000 women screened; Monsonego J ;2004;;
Noneg;parmigiani2002.pdf;modeling and optimization in early detection programs with a single exam;Parmigiani G, Skates S, Zelen M;2002;;
q12;taksler2016.pdf;modeling individual patient preferences for colorectal cancer screening based on their tolerance for complications risk;Glen B Taksler, Adam T Perzynski, Michael W Kattan, ;2016;;
Noneg;rafia2015.pdf;Modeling the cost-effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales;Rafia R, Brennan A, Madan J, Collins K, Reed MW, Lawrence G, Robinson T, Greenberg D, Wyld L;2015;;
Noneg;subramanian2009.pdf;modeling the cost-effectiveness of colorectal cancer screening policy guidance based on patient preferences and compliance;Sujha Subramanian, Georgiy Bobashev, Robert J Morris;2009;;
FromReview;berry2006.pdf;Supplemental Perioperative Oxygen and the Risk of Surgical Wound Infection: A Randomized Controlled Trial;F Javier Belda, Luciano Aguilera, Jose Garca de la Asuncion,Javier Alberti, Rosario Vicente, Luca Ferrandiz, Rafael Rodriquez,Roque Company, Daniel I Sessler, Gerardo Aguilar,Stephanie Garca Botello, Rafael Orti;2006;;
Anton;schlecht2003.pdf;modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions;Schlecht NF, Platt RW, Negassa A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL;2003;;
Noneg;nnoaham2008.pdf;modelling future capacity needs and spending on colonoscopy in the english bowel cancer screening programme;Nnoaham KE, Lines C;2008;;
FromReview;nihms783893.pdf;modelling mammography screening for breast cancer in the canadian context modification and testing of a microsimulation model;Yaffe Martin J, Mittmann Nicole, Lee Pablo, Tosteson Anna N A, Trentham-Dietz Amy, Alagoz Oguzhan, Stout Natasha K;2015;;
FromReview;lee2003.pdf;Modelling the early detection of breast cancer;S J Lee, M Zelen;2003;;
Anton;demarteau2010.pdf;modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer;Demarteau N, Standaert B;2010;;
Noneg;uhry2011.pdf;modelling the effect of breast cancer screening on related mortality using french data;Uhry Z, Hdelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molini F, Trtarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S;2011;;
Noneg;etzioni2004.pdf;modelling the effect of screening for cervical cancer on the population;Ruth Etzioni, David B Thomas;2004;;
Noneg;johnston2001.pdf;modelling the future costs of breast screening;Johnston K;2001;;
Noneg;taylor2010.pdf;modelling the impact of changes in sensitivity on the outcomes of the uk breast screening programme;Taylor P;2010;;
q12;mccann2004.pdf;Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme;McCann J, Treasure P, Duffy S;2004;;
Noneg;woo2005.pdf;modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in hong kong an age-period-cohort approach;Woo PPS, Thach TQ, Choy STB, McGhee SM, Leung GM;2005;;
q12;canfell2010.pdf;models of cervical screening in the era of human papillomavirus vaccination;Canfell K;2010;;
Noneg;blanks2004.pdf;monitoring and evaluating the performance of the uk nhs cervical screening programme monitoring performance by using cytology outcomes adjusted for population characteristics;R G Blanks, M Waller, A Sanchez-Galvez, S M Moss;2004;;
Noneg;berkowitz2018.pdf;multilevel small-area estimation of colorectal cancer screening in the united states;Berkowitz Z, Zhang X, Richards TB, Nadel M, Peipins LA, Holt J;2018;;
Noneg;sutradhar2016.pdf;multistate transitional models for measuring adherence to breast cancer screening a population-based longitudinal cohort study with over two million women;Sutradhar R, Gu S, Paszat LF,;2016;;
Noneg;berkhof2005.pdf;natural history and screening model for high-risk human papillomavirus infection neoplasia and cervical cancer in the netherlands;Berkhof J, de Bruijne MC, Zielinski GD, Meijer CJ;2005;;
Anton;10.1002@cncr.29952.pdf;nonbleeding adenomas evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-a modeling study;Miriam P van der Meulen, Iris Lansdorp-Vogelaar, Else-Mariette B van Heijningen, Ernst J Kuipers, Marjolein van Ballegooijen;2016;;
Anton;price2016.pdf;Operations research models and methods in the screening, detection, and treatment of prostate cancer: A categorized, annotated review;Stuart Price, Bruce Golden, Edward Wasil, Brian Denton;2015;;
Anton;steen2015.pdf;Optimal Colorectal Cancer Screening in States? Low-Income, Uninsured Populations The Case of South Carolina;Alex van der Steen, Amy B. Knudsen, Frank van Hees,Gailya P. Walter, Franklin G. Berger, Virginie G. Daguise, Karen M. Kuntz, Ann G. Zauber, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar;2015;;
Noneg;sekiguchi2015.pdf;optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening a cost-effectiveness analysis using japanese data;Masau Sekiguchi, Ataru Igarashi, Takahisa Matsuda,Minori Matsumoto, Taku Sakamoto, Takeshi Nakajima,Yasuo Kakugawa, Seiichiro Yamamoto, Hiroshi Saito, Yutaka Saito;2015;;
q12;rogoza2008.pdf;optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination a multi-regional health economic analysis;Rogoza RM, Ferko N, Bentley J, Meijer CJ, Berkhof J, Wang KL, Downs L, Smith JS, Franco EL;2008;;
FromReview;zhang2012.pdf;Optimization of Prostate Biopsy Referral Decisions;Jingyu Zhang, Brian T Denton, Hari Balasubramanian, Nilay D Shah, Brant A Inman;2012;;
FromReview;zhang2011.pdf;Optimization of PSA Screening Policies: A Comparison of the Patient and Societal Perspectives;Jingyu Zhang, Brian T Denton, Hari Balasubramanian,vNilay D Shah, Brant A Inman;2012;;
Noneg;meester2018.pdf;optimizing colorectal cancer screening by race and sex microsimulation analysis ii to inform the american cancer society colorectal cancer screening guideline;Reinier G S Meester, Elisabeth F P Peterse, Amy B Knudsen, Anne C de Weerdt, Jennifer C Chen, Anna P Lietz, BA Andrea Dwyer, Dennis J Ahnen, Rebecca L Siegel, Robert A Smith, Ann G Zauber, Iris Lansdorp-Vogelaar;2018;;
Noneg;wong2012.pdf;optimizing resource allocation for breast cancer prevention and care among hong kong chinese women;Irene O L Wong, MPhil Janice W H Tsang, Benjamin J Cowling, Gabriel M Leung;2012;;
FromReview;tappenden2007.pdf;option appraisal of population-based colorectal cancer screening programmes in england;Tappenden P, Chilcott J, Eggington S, Patnick J, Sakai H, Karnon J;2007;;
Anton;10.1186@bcr1369.pdf;overdiagnosis and overtreatment of breast cancer microsimulation modelling estimates based on observed screen and clinical data;de Koning HJ, Draisma G, Fracheboud J, de Bruijn A;2007;;
Noneg;nghiem2016.pdf;overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancer;Van T Nghiem, Kalatu R Davies, J Robert Beck, Michele Follen, Scott B Cantor;2016;;
Anton;10.1016@s0959-80490000330-0.pdf;Overview of important cervical cancer screening process values inEuropean Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness;Van Ballegooijen M, Van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, Ronco G, Dik J, Habbema F;2000;;
Noneg;10.1371@journal.pmed.1002225.pdf;performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting a microsimulation modeling analysis in ontario canada;Ten Haaf K, Tammemgi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF,;2016;;
Anton;arnold2018.pdf;personalized mammography screening and screening adherence-a simulation and economic evaluation;Matthias Arnold, Anne S Quante ;2018;;
Noneg;subramanian2017.pdf;Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?;Subramanian Sujha, Bobashev Georgiy, Morris Robert J, Hoover Sonja;2017;;
FromReview;macafee2008.pdf;population screening for colorectal cancer the implications of an ageing population;DAL Macafee, M Waller, DK Whynes, S Moss, JH Scholefield;2008;;
Noneg;marshall2001.pdf;Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort;Marshall D, Simpson KN, Earle CC, Chu C;2001;;
q12;kulasingam2003.pdf;Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs;Kulasingam SL, Myers ER;2003;;
Noneg;seppnen2008.pdf;predicting impacts of mass-screening policy changes on breast cancer mortality;Seppnen J, Heinvaara S, Hakulinen T;2008;;
Anton;chiu2017.pdf;predicting the effectiveness of the finnish population-based colorectal cancer screening programme;Sherry Yueh-Hsia Chiu, Nea Malila, Amy Ming-Fang Yen,Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Matti Hakama;2017;;
Noneg;parkin2008.pdf;predicting the impact of the screening programme for colorectal cancer in the uk;DM Parkin, P Tappenden, A H Olsen, J Patnick, P Sasieni;2008;;
Noneg;castanon2018.pdf;prediction of cervical cancer incidence in england uk up to 2040 under four scenarios a modelling study;Alejandra Castanon, Rebecca Landy, Francesca Pesola, Peter Windridge, Peter Sasieni;2017;;
Anton;10.1038@bjc.2011.300.pdf;prediction of higher mortality reduction for the uk breast screening frequency trial a model-based approach on screening intervals;NT van Ravesteyn, EAM Heijnsdijk, G Draisma, HJ de Koning;2011;;
q12;canfell2011.pdf;prevention of cervical cancer in rural china evaluation of hpv vaccination and primary hpv screening strategies;Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith, Nickson C, Qiao YL;2011;;
Noneg;10.1136@bmj.e670.pdf;Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: costeffectiveness analysis based on a Dutch microsimulation model;de Kok IM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, van Ballegooijen M;2011;;
Noneg;tafazzoli2009.pdf;probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer;Tafazzoli Ali, Roberts Stephen, Klein Robert, Ness Reid, Dittus Robert;2009;;
Noneg;rojnik2008.pdf;probabilistic cost-effectiveness modeling of different breast cancer screening policies in slovenia;Rojnik K, Naversnik K, Mateovi-Rojnik T, Primiczakelj M;2008;;
q12;bradley2011.pdf;Productivity Savings from Colorectal Cancer Prevention and Control Strategies;Cathy J Bradley, Iris Lansdorp-Vogelaar, K Robin Yabroff,Bassam Dahman, Angela Mariotto, Eric J Feuer, Martin L Brown, ;2011;;
Noneg;melnikow2013.pdf;program-specific cost-effectiveness analysis breast cancer screening policies for a safety-net program;Melnikow J, Tancredi DJ, Yang Z, Ritley D, Jiang Y, Slee C, Popova S, Rylett P, Knutson K, Smalley S;2013;;
Anton;roth2015.pdf;projected clinical resource use and fiscal impacts of implementing low-dose computed tomography lung cancer screening in medicare;By Joshua A Roth, Sean D Sullivan, Bernardo HL Goulart,Arliene Ravelo, Joanna C Sanderson, Scott D Ramsey ;2015;;
FromReview;stensson2013.pdf;Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program;Ellinor Ostensson, Ann-Cathrin Hellstrom, Kristina Hellman, Inger Gustavsson,Ulf Gyllensten, Erik Wilander, Niklas Zethraeus, Sonia Andersson;2013;;
Noneg;coldman2017.pdf;Simulating Results from Trials of Sigmoidoscopy Screening Using the OncoSim Microsimulation Model;Andrew Coldman, Joy Pader, Cynthia Gauvreau,Saima Memon, Natalie Fitzgerald, William Flanagan, ClaudeNadeau, Craig Earle, Michael Wolfson, Anthony Miller, JasonLacombe;2017;;
Anton;10.1080@21645515.2015.1054584.pdf;Projected impact of Cervarix vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom;Van Effelterre TP, Hogea C, Taylor SM;2015;;
Noneg;stone2005.pdf;prostate cancer the psa test and academic detailing in australian general practice an economic evaluation;Stone CA, May FW, Pinnock CB, Elwood M, Rowett DS;2005;;
Anton;matthijsse2016.pdf;public health benefits of routine human papillomavirus vaccination for adults in the netherlands a mathematical modeling study;Matthijsse SM, Hontelez JA, Naber SK, Rozemeijer K, de Kok IM, Bakker R, van Ballegooijen M, van Rosmalen J, de Vlas SJ;2016;;
Anton;meester2015.pdf;public health impact of achieving 80 colorectal cancer screening rates in the united states by 2018;Reinier G Meester, Chyke A Doubeni, Ann G Zauber, Luuk Goede, Theodore R Levin,Douglas A Corley, Ahmedin Jemal, Iris Lansdorp-Vogelaar;2018;;
Anton;10.1007@s00038-011-0273-5.pdf;public health impact of human papillomavirus vaccination on prevention of cervical cancer in france;El Hasnaoui A, Demarteau N, Granados D, Standaert B, Detournay B;2011;;
Anton;yang2018.pdf;quality assurance target for community-based breast cancer screening in china a model simulation;Lan Yang, Jing Wang, Juan Cheng, Yuan Wang, Wenli Lu;2018;;
Anton;10.2307@40271855.pdf;quantifying the role of psa screening in the us prostate cancer mortality decline;Ruth Etzioni, Alex Tsodikov, Angela Mariotto, Aniko Szabo, Seth Falcon, JakeWegelin, Dante diTommaso, Kent Karnofski, Roman Gulati, David F Penson, Eric Feuer;2008;;
Noneg;heijnsdijk2014.pdf;Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data;E A M Heijnsdijk, T M de Carvalho, A Auvinen, M Zappa,V Nelen, M Kwiatkowski, A Villers, A Pez, S M Moss,T L J Tammela, F Recker, L Denis, SV Carlsson, E M Wever,C H Bangma, F H Schrder, M J Roobol, J Hugosson, H J de Koning;2014;;
Noneg;whyte2012.pdf;reappraisal of the options for colorectal cancer screening in england;Whyte S, Chilcott J, Halloran S;2012;;
Noneg;eaker2001.pdf;reasons women do not attend screening for cervical cancer a population-based study in sweden;Eaker S, Adami H-O, Sparen P;2001;;
Noneg;knudsen2012.pdf;rescreening of persons with a negative colonoscopy result results from a microsimulation model;Amy B Knudsen, Chin Hur, G Scott Gazelle, Deborah Schrag, Elizabeth G McFarland, Karen M Kuntz;2012;;
Anton;nihms451467.pdf;response reading between the lines of cancer screening trials using modeling to understand the evidence;Etzioni Ruth, Gulati Roman;2013;;
FromReview;jeong2013.pdf;Review of economic evidence in the prevention and early detection of colorectal cancer;Kim E Jeong, John A Cairns;2013;;
Noneg;morrell2012.pdf;Screening for prostate cancer using multivariate mixed-effects models;Christopher H Morrell, Larry J Brant, Shan Sheng, E Jeffrey Metter;2012;;
FromReview;lee1998.pdf;Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer;Sandra J Lee, Marvin Zelen;1998;;
Noneg;beemsterboer1998.pdf;screening for breast cancer in catalonia - which policy is to be preferred;Beemsterboer, PMM, Warmerdam, PG, Boer, R, Borras, JM, Moreno, V, Viladiu, P, De Koning, HJ;1998;;
Anton;10.1002@ijc.29136.pdf;Screening for prostate cancer in the US? Reduce the harms and keep the benefit;Tiago M de Carvalho, Eveline AM Heijnsdijk, Harry J de Koning;2014;;
FromReview;10.7326@m13-2263.pdf;Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A cost-effectiveness Analysis;Frank van Hees, J Dik F Habbema, Reinier G Meester, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Ann G Zauber;2014;;
Noneg;klemi2003.pdf;significant improvement in breast cancer survival through population-based mammography screening;Klemi PJ, Parvinen I, Pylkknen L, Kauhava L, Immonen-Rih P, Rsnen O, Helenius H;2003;;
q12;10.1177@0272989x17711928.pdf;simulating the impact of risk-based screening and treatment on breast cancer outcomes with miscan-fadia;Jeroen J van den Broek, Nicolien T van Ravesteyn,Eveline A Heijnsdijk, Harry J de Koning;2017;;
Noneg;hunter2004.pdf;simulation modeling of change to breast cancer detection age eligibility recommendations in ontario 2002-2021;Hunter DJ, Drake SM, Shortt SE, Dorland JL, Tran N;2004;;
FromReview;10.1016@j.bpg.2010.07.001.pdf;Simulation of colorectal cancer screening: What we do and do not know and does it matter;Marjolein van Ballegooijen, Rob Boer, Ann G Zauber;2010;;
FromReview;underwood2012.pdf;simulation optimization of psa-threshold based prostate cancer screening policies;Daniel J Underwood, Jingyu Zhang, Brian T Denton, Nilay D Shah, Brant A Inman;2012;;
Anton;goldwasser2012.pdf;small median tumor diameter at cure threshold20 mm among aggressive non-small cell lung cancers in male smokers predicts both chest x-ray and ct screening outcomes in a novel simulation framework;Deborah L Goldwasser, Marek Kimmel;2012;;
Noneg;boer1999.pdf;stage distribution at first and repeat examinations in breast cancer screening;Boer R, de Koning H, van Oortmarssen G, Warmerdam P, van der Maas P;1999;;
Noneg;crt-2016-525.pdf;strategic distributional cost-effectiveness analysis for improving national cancer screening uptake in cervical cancer a focus on regional inequality in south korea;Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH,;2018;;
q12;kivutibitok2014.pdf;system dynamics model of cervical cancer vaccination and screening interventions in kenya;Lucy W Kivuti-Bitok, Geoff McDonnell, Roudsari Abdul, Ganesh P Pokhariyal;2014;;
FromReview;mendes2015.pdf;Systematic review of model-based cervical screening evaluations;Diana Mendes, Iren Bains, Tazio Vanni, Mark Jit;2015;;
Anton;felix2016.pdf;the clinical and economic benefits of co-testing versus primary hpv testing for cervical cancer screening a modeling analysis;Juan C Felix, Michael J Lacey, Jeffrey D Miller, Gregory M Lenhart,Mark Spitzer, Rucha Kulkarni;2016;;
FromReview;gangnon2015.pdf;The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-period-cohort Model;Ronald E Gangnon, Brian L Sprague, Natasha K Stout, Oguz Alagoz, Harald Weedon-Fekjr,Theodore R Holford, Amy Trentham-Dietz,;2015;;
Noneg;field2013.pdf;the contribution of risk prediction models to early detection of lung cancer;Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW;2013;;
Noneg;anderson2008.pdf;the cost-effectiveness of cervical screening in australia what is the impact of screening at different intervals or over a different age range;Anderson R, Haas M, Shanahan M;2008;;
Noneg;lejeune2014.pdf;the cost-effectiveness of immunochemical tests for colorectal cancer screening;Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J;2014;;
FromReview;wisnivesky2003.pdf;The cost-effectiveness of Low-Dose CT Screening for Lung Cancer*Preliminary Results of Baseline Screening;Juan P Wisnivesky, Alvin I Mushlin, Nachum Sicherman, Claudia Henschke ;2003;;
FromReview;dewilde2004.pdf;the cost-effectiveness of screening programs using single and multiple birth cohort simulations a comparison using a model of cervical cancer;Dewilde S, Anderson R;2004;;
Noneg;sander2016.pdf;the cost-utility of integrated cervical cancer prevention strategies in the ontario setting - can we do better;Beate Sandera, William WL Wong, Man Wah Yeung, Orges Ormanidhi,Karen Atkin, Joan Murphy, Murray Krahn, Shelley L Deeks,;2016;;
FromReview;lee2018.pdf;The Dana-Farber CISNET Model for BreastCancer Screening Strategies: An Update;Sandra J Lee, Xiaoxue Li, Hui Huang, Marvin Zelen;2017;;
q12;birnbaum2016.pdf;the effect of treatment advances on the mortality results of breast cancer screening trials a microsimulation model;Birnbaum J, Gadi VK, Markowitz E, Etzioni R;2016;;
Noneg;campos2017.pdf;the health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries;Nicole G Campos, Monisha Sharma, Andrew Clark, Kyueun Lee, Fangli Geng, Catherine Regan, Jane Kim, Stephen Resch;2017;;
q12;tay2011.pdf;the impact of cytology screening and hpv vaccination on the burden of cervical cancer;Tay K, Tay SK;2011;;
Anton;hestbech2015.pdf;the impact of hpv vaccination on future cervical screening a simulation study of two birth cohorts in denmark;Mie Sara Hestbech, Elsebeth Lynge, Jakob Kragstrup, Volkert Siersma,Miguel Vazquez-Prada Baillet, John Brodersen;2015;;
Noneg;ventura2014.pdf;the impact of immunochemical faecal occult blood testing on colorectal cancer incidence;Leonardo Ventura, Paola Mantellini, Grazia Grazzini, Guido Castiglione, Carlotta Buzzoni,Tiziana Rubeca, Claudio Sacchettini, Eugenio Paci, Marco Zappa ;2014;;
Anton;han2017.pdf;The impact of overdiagnosis on the selection of efficient lung cancer screening strategies;Summer S Han, Kevin ten Haaf, William D Hazelton, Vidit N Munshi, Jihyoun Jeon,Saadet A Erdogan, Colden Johanson, Pamela M McMahon, Rafael Meza, Chung YinKong, Eric J Feuer, Harry J de Koning, Sylvia K Plevritis;2017;;
Noneg;goede2015.pdf;the impact of stratifying by family history in colorectal cancer screening programs;Simon Lucas Goede, Linda Rabeneck, Iris Lansdorp-Vogelaar, Ann G Zauber, Lawrence F Paszat,Jeffrey S Hoch, Jean HE Yong, Frank van Hees, Jill Tinmouth, Marjolein van Ballegooijen;2015;;
Noneg;peterse2018.pdf;the impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening microsimulation analysis i to inform the american cancer society colorectal cancer screening guideline;Elisabeth FP Peterse, Reinier GS Meester, Rebecca L Siegel, Jennifer C Chen, Andrea Dwyer, Dennis J Ahnen, Robert A Smith, Ann G Zauber, Iris Lansdorp-Vogelaar, ;2018;;
Noneg;omahony2014.pdf;the influence of disease risk on the optimal time interval between screens for the early detection of cancer a mathematical approach;OMahony JF, van Rosmalen J, Mushkudiani NA, Goudsmit FW, Eijkemans MJ, Heijnsdijk EA, Steyerberg EW, Habbema JD;2014;;
Noneg;chauvin2013.pdf;The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening;Chauvin P, Josselin JM, Heresbach D;2013;;
Anton;wu2012.pdf;The Lead Time Distribution When Lifetime is Subject to Competing Risks in Cancer Screening;Wu D, Kafadar K, Rosner GL, Broemeling LD;2012;;
Anton;schillerfruehwirth2017.pdf;the long-term effectiveness and cost-effectiveness of organized versus opportunistic screening for breast cancer in austria;Irmgard Schiller-Fruehwirth, Beate Jahn, Patrick Einzinger,Gunther Zauner,Christoph Urach, Uwe Siebert;2017;;
Noneg;loeve1999.pdf;the miscan-colon simulation model for the evaluation of colorectal cancer screening;Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JDF;1999;;
Anton;muhlberger2015.pdf;the oncotyrol prostate cancer outcome and policy model effect of prevalence assumptions on the benefit-harm balance of screening;Nikolai Muehlberger, Christina Kurzthaler, Rowan Iskandar,Murray D Krahn, Karen E Bremner, Willi Oberaigner, Helmut Klocker, Wolfgang Horninger, Annette Conrads-Frank, Gaby Sroczynski, Siebert Uwe;2015;;
q12;sinanovic2009.pdf;the potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in south africa;Sinanovic E, Moodley J, Barone, Mall S, Cleary S, Harries J;2009;;
Noneg;naber2016.pdf;the potential harms of primary human papillomavirus screening in over-screened women a microsimulation study;Naber SK, de Kok IM, Matthijsse SM, van Ballegooijen M;2016;;
Anton;korostil2014.pdf;The potential impact of HPV-16 reactivation on prevalence in older Australians;Korostil IA, Regan DG;2014;;
Noneg;canfell2004.pdf;the predicted effect of changes in cervical screening practice in the uk results from a modelling study;Canfell K, Barnabas R, Patnick J, Beral V;2004;;
Noneg;castro2005.pdf;the relation of breast cancer staging to screening protocol compliance a computer simulation study;Castro F, Carter KJ, Kessler E, Erickson BA, Kseibi SA;2005;;
Anton;matthijsse2015.pdf;the role of acquired immunity in the spread of human papillomavirus hpv explorations with a microsimulation model;Matthijsse SM, van Rosmalen J, Hontelez JA, Bakker R, de Kok IM, van Ballegooijen M, de Vlas SJ;2015;;
Noneg;siddiqui2011.pdf;the role of physician reminders in faecal occult blood testing for colorectal cancer screening;Muhammed Rafay Sameem Siddiqui, Muhammad Shafiq Sajid,Kamran Khatri, Bipul Kanri, Elizabeth Cheek, Mirza Khurrum Baig;2011;;
q12;lgj008.pdf;the spectrum population model of the impact of screening and treatment on us breast cancer trends from 1975 to 2000 principles and practice of the model methods;Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J;2006;;
Noneg;lgj010.pdf;the university of rochester model of breast cancer detection and survival;Hanin LG, Miller A, Zorin AV, Yakovlev AY;2006;;
q12;feuer2004.pdf;The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing;Feuer EJ, Etzioni R, Cronin KA, Mariotto A;2004;;
Noneg;older.pdf;the value of colonoscopic colorectal cancer screening of adults aged 50 to 64 years;Kathryn Fitch, Pyenson Bruce, Blumen Helen, Weisman Thomas, Small Art;2015;;
Anton;burger2014.pdf;the value of improving failures within a cervical cancer screening program an example from norway;Burger EA, Kim JJ;2014;;
q12;sharma2015.pdf;The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting;Sharma M, Sy S, Kim JJ;2015;;
Noneg;lgj007.pdf;the wisconsin breast cancer epidemiology simulation model;Dennis G Fryback, Natasha K Stout, Marjorie A Rosenberg, Amy Trentham-Dietz,Vipat Kuruchittham, Patrick L Remington;2006;;
Noneg;10.7326@0003-4819-156-9-201205010-00002.pdf;tipping the balance of benefits and harms to favor screening mammography starting at age 40 years a comparative modeling study of risk;van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ;2012;;
Noneg;campos2017 (1).pdf;The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries;Nicole G Campos, Jose Jeronimo, Vivien Tsu, Philip E Castle, Mercy Mvundura, Jane J Kima;2017;;
Noneg;jgi_05076.pdf;toward optimal screening strategies for older women costs benefits and harms of breast cancer screening by age biology and health status;Jeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff,William Lawrence, James Dignam, Martine Extermann,Sarah Fox, Gretchen Orosz, Rebecca Silliman,Jennifer Cullen, Lodovico Balducci;2005;;
Anton;choi2010.pdf;transmission dynamic modelling of the impact of human papillomavirus vaccination in the united kingdom;Choi YH, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ;2010;;
Noneg;bergstrm1999.pdf;trends in cancer of the cervix uteri in sweden following cytological screening;Bergstrom R, Sparen P, Adami H-O;1999;;
Anton;barnett2017.pdf;two-stage biomarker protocols for improving the precision of early detection of prostate cancer;Christine L Barnett, Scott A Tomlins, Daniel J Underwood,John T Wei, Todd M Morgan, James E Montie, Brian T Denton ;2017;;
Noneg;campbell2016.pdf;understanding the effects of competition for constrained colonoscopy services with the introduction of population-level colorectal cancer screening a discrete event simulation model;Leslie Anne Campbell, John T Blake, George Kephart,Eva Grunfeld, Donald MacIntosh, ;2016;;
q12;beaber2015.pdf;Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical,and Colorectal Cancer Screening;Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA Population-based Research Optimizing Screening through Personalized Regimens Consortium;2015;;
Noneg;duffy2009.pdf;Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer;Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK;2009;;
Noneg;ramsey2000.pdf;SIMULATION MODELING  OF OUTCOMES AND COST-EFFECTIVENESS ;Ramsey SD, McIntosh M, Etzioni R, Urban N;2000;;
Noneg;ramos2005.pdf;Use of risk projection models to estimate mortality and incidence from radiation-induced breast cancer in screening programs;M Ramos, S Ferrer, J I Villaescusa, G Verdu, M D Salas, M D Cuevas;2005;;
Noneg;carney2014.pdf;using computational modeling to assess the impact of clinical decision support on cancer screening improvement strategies within the community health centers;Jay Timothy Carney, Morgan Geoffrey P, Jones Josette, Anna M McDaniel, Michael Weaver, Bryan Weiner, David A Haggstrom ;2014;;
Noneg;sharp2013.pdf;Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland;Linda Sharp, Lesley Tilson, Sophie Whyte, Alan O Ceilleachair, Cathal Walsh, Cara Usher, Paul Tappenden,James Chilcott, Anthony Staines, Michael Barry, Harry Comber;2013;;
Noneg;taghipour2016.pdf;using simulation to model and validate invasive breast cancer progression in women in the study and control groups of the canadian national breast screening studies i and ii;Taghipour S, Caudrelier LN, Miller AB, Harvey B;2016;;
Noneg;mclay2010.pdf;using simulation-optimization to construct screening strategies for cervical cancer;Laura A McLay, Christodoulos Foufoulides, Jason R W Merrick;2010;;
Noneg;coldman2015.pdf;using the cancer risk management model to evaluate colorectal cancer screening options for canada;Coldman A J, Phillips N, Brisson J, Flanagan W, Wolfson M, Nadeau C, Fitzgerald N, Miller A B;2013;;
Anton;rutter2016.pdf;validation of models used to inform colorectal cancer screening guidelines accuracy and implications;Carolyn M Rutter, Amy B Knudsen, Tracey L Marsh,V Paul Doria-Rose, Eric Johnson, Chester Pabiniak,Karen M Kuntz, Marjolein van Ballegooijen,Ann G Zauber, Iris Lansdorp-Vogelaar;2016;;
Anton;nevalainen2017.pdf;what explains the differences between centres in the european screening trial a simulation study;Jaakko Nevalainen, Ulf-Hkan Stenman, Teuvo L Tammela, Monique Roobol,Sigrid Carlsson, Kirsi Talala, Fritz H Schrder, Anssi Auvinen;2017;;
Noneg;lynge2006.pdf;What happens when organization of cervical cancer screening is delayed or stopped?;Lynge E, Clausen LB, Guignard R, Poll P;2006;;
Noneg;document(1).pdf;What is the most cost-effective screening regimen for colon cancer?;Susan Griffith, Kevin Y Kane;2001;;
q12;mandelblatt2013.pdf;which strategies reduce breast cancer mortality most;Jeanne Mandelblatt, Nicolien van Ravesteyn, Clyde Schechter, Yaojen Chang, An-Tsun Huang, Aimee M Near, Harry de Koning, Ahmedin Jemal ;2013;;
Noneg;belkar2005.pdf;why worry about awareness in choice problems econometric analysis of screening for cervical cancer;Belkar R, Fiebig DG, Haas M, Viney R;2005;;
FromReview;mandelblatt2016.pdf;Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies;Jeanne S Mandelblatt, Natasha K Stout, Clyde B Schechter, Jeroen J van den Broek, Diana L Miglioretti, Martin Krapcho, Amy Trentham-Dietz, Diego Munoz, Sandra J Lee, Donald A Berry, Nicolien T van Ravesteyn, Oguzhan Alagoz, Karla Kerlikowske, Anna NA Tosteson, Aimee M Near, Amanda Hoeffken, Yaojen Chang, Eveline A Heijnsdijk, Gary Chisholm, Xuelin Huang, Hui Huang, Mehmet Ali Ergun, Ronald Gangnon, Brian L Sprague, Sylvia Plevritis, Eric Feuer, Harry J de Koning, Kathleen A Cronin;2016;;
Noneg;loeve2000.pdf;Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis;Franka Loeve, Martin L Brown, Rob Boer, Marjolein van Ballegooijen, Gerritt J van Oortmarssen, J Dik F Habbema;2000;;
Anton;nihms331310.pdf;Long-term Projections of the Number Needed to Screen and Additional Number Needed to Treat in Prostate Cancer Screening;Roman Gulati, Angela B Mariotto, Shu Chen, John L Gore, Ruth Etzioni ;2011;;
Noneg;clries2013.pdf;Predicting the Change in Breast Cancer Deaths in Spain by 2019;Ramon Clries, Jose Miguel Martnez, Victor Moreno, Yutaka Yasui, Josepa Ribes, Josep Maria Borras;2013;;
Noneg;sawaya2003.pdf;Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings;George F Sawaya, K John McConnell, Shalini L Kulasingam, Herschel W Lawson,Karla Kerlikowske, Joy Melnikow, Nancy C Lee, Ginny Gildengorin,Evan R Myers, A Eugene Washington, ;2003;;
FromReview;lansdorpvogelaar2010.pdf;Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population;Iris Lansdorp-Vogelaar, Karen M Kuntz, Amy B Knudsen, Janneke A Wilschut, Ann G Zauber, Marjolein van Ballegooijen, ;2010;;
Noneg;campos2016.pdf;To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings;Nicole G Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Kyueun Lee, Jane J Kim;2016;;
Missed;campos2017_3.pdf;Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.;Nicole G Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Jane J Kim;2017;;
Missed;campos2017_4.pdf;Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.;Nicole G Campos, Mercy Mvundura, Jose Jeronimo, Francesca Holme,Elisabeth Vodicka, Jane J Kim;2017;;
Missed;coldman2017_2.pdf;Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model;Andrew Coldman, Joy Pader, Cynthia Gauvreau,Saima Memon, Natalie Fitzgerald, William Flanagan, ClaudeNadeau, Craig Earle, Michael Wolfson, Anthony Miller, JasonLacombe;2017;;
Missed;cronin1998.pdf;Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.;Kathleen A. Cronin, Julie M. Legler, Ruth D. Etzioni;1998;;
Missed;Dongfeng2012.pdf;INFERENCE OF LONG TERM EFFECTS AND OVERDIAGNOSIS IN PERIODIC CANCER SCREENING;Dongfeng Wu, Karen Kafadar, Gary L. Rosner;2012;;
Missed;Economic_Models_Workshop.pdf;economic models of colorectal cancer screening in average-risk adults: workshop summary;Michael Pignone, Louise Russell, Judith Wagner;2005;;
Missed;fett2001.pdf;Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval;Fett, MJ;2001;;
Missed;fitzgerald2015.pdf;Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals;Fitzgerald NR, Flanagan WM, Evans WK, Miller AB;2015;;
Missed;goede2015_2.pdf;Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening;Simon L Goede, Karen M Kuntz, Marjolein van Ballegooijen,Amy B Knudsen, Iris Lansdorp-Vogelaar, Florence K Tangka,David H Howard, Joseph Chin, Ann G Zauber, Laura C Seeff;2015;;
Missed;gulati2011_2.pdf;Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates;Roman Gulati, Angela B Mariotto, Shu Chen, John L Gore, Ruth Etzioni;2011;;
Missed;haug2014_2.pdf;Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.;Haug U, Knudsen AB, Lansdorp-Vogelaar I, Kuntz KM;2014;;
Missed;imperiale2004.pdf;fecal dna versus fecal occult blood for colorectal-cancer screening in an average-risk population;Thomas F Imperiale, David F Ransohoff, Steven H Itzkowitz,Barry A Turnbull, Michael E Ross;2004;;
Missed;kamphuis2017.pdf;Effect of Cervical Cancer Screening Programs on Preterm Birth: A Decision and Cost-Effectiveness Analysis.;Esme I Kamphuis, Steffie K Naber, Noor A Danhof, J Dik F Habbema,Christianne J M de Groot, Ben W J Mol;2017;;
Missed;Koning2018.pdf;The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials;Harry J de Koning, Roman Gulati, Sue M Moss, Jonas Hugosson, Paul F Pinsky, Christine D Berg, Anssi Auvinen, Gerald L Andriole, Monique J Roobol, E David Crawford, Vera Nelen, Maciej Kwiatkowski, Marco Zappa, Marcos Lujan, Arnauld Villers, Tiago M de Carvalho, Eric J Feuer, Alex Tsodikov, Angela B Mariotto, Eveline AM Heijnsdijk, Ruth Etzioni;2017;;
Missed;lam2004.pdf;The price of cancer screening;Lam CLK;2004;;
Missed;landy2017_2.pdf;What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study;Rebecca Landy, Peter Windridge, Matthew S Gillman, Peter D Sasieni;2017;;
Missed;Lee2016_2.pdf;Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered;Lee Kwang-Sig, Park Eun-Cheol;2016;;
Missed;mandelblatt2002_2.pdf;Costs and benefits of different strategies to screen for cervical cancer in less-developed countries;Jeanne S Mandelblatt, William F Lawrence, Lynne Gaffikin, Khunying Kobchitt Limpahayom, Pisake Lumbiganon, Suwanna Warakamin, Jason King, Bin Yi,Patricia Ringers, Paul D Blumenthal;2002;;
Missed;mandelblatt2004_2.pdf;Benefits and costs of interventions to improve breast cancer outcomes in African American women.;Jeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff, William Lawrence, James Dignam,Peter Muennig, Yoko Chavez, Jennifer Cullen, Marianne Fahs;2004;;
Missed;mandelblatt2011_2.pdf;Modeling the impact of population screening on breast cancer mortality in the United States;Jeanne S Mandelblatt, Kathleen A Cronin, Donald A Berry, Yaojen Chang, Harry J de Koning,Sandra J Lee, Sylvia K Plevritis, Clyde B Schechter, Natasha K Stout, Nicolien T van Ravesteyn,Marvin Zelen, Eric J Feuer;2011;;
Missed;marshall2001_2.pdf;Economic decision analysis model of screening for lung cancer;Marshall D, Simpson KN, Earle CC, Chu C-W;2001;;
Missed;neville2005.pdf;An alternative cost effectiveness analysis of ThinPrep in the Australian setting.;A Munro Neville, Michael A Quinn;2005;;
Missed;Perez2016.pdf;Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation;Ulloa-Perez E, Mohar-Betancourt A, Reynoso-Noveron N;2016;;
Missed;Ravesteyn2010.pdf;Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.;Nicolien T van Ravesteyn, Clyde B Schechter, Aimee M Near, Eveline AM Heijnsdijk, Michael A Stoto,Gerrit Draisma, Harry J de Koning, Jeanne S Mandelblatt;2010;;
Missed;roth2016_2.pdf;Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies;Joshua A Roth, Roman Gulati, John L Gore, Matthew R Cooperberg, Ruth Etzioni ;2016;;
Missed;shen1999.pdf;parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding;Yu Shen, Marvin Zelen;1999;;
Missed;shen2005_2.pdf;robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution;Yu Shen, Marvin Zelen;2005;;
Missed;simonella2015.pdf;development of a quality framework for models of cervical screening and its application to evaluations of the costeffectiveness of hpv vaccination in developed countries;Leonardo Simonella, Karen Canfell;2014;;
Missed;Tan2000.pdf;estimating parameters of a microsimulation model for breast cancer screening using the score function method;Sita YGL Tan, Gerrit J van Oortmarssen, Nanda Piersma ;2000;;
Missed;Taylor2000.pdf;Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.;Taylor LA, Sorensen SV, Ray NF, Halpern MT, Harper DM;2000;;
Missed;Thomas2017.pdf;Estimating the Effect of Targeted Screening Strategies An Application to Colonoscopy and Colorectal Cancer;Thomas, Duncan C;2017;;
Missed;vervoort2004.pdf;Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.;Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ;2004;;
Missed;vogelaar2006.pdf;How much can current interventions reduce colorectal cancer mortality in the US? Mortality projections for scenarios of risk-factor modification, screening, and treatment;Vogelaar Iris, van Ballegooijen Marjolein, Schrag Deborah, Boer Rob, Winawer Sidney J, Habbema J Dik F, Zauber Ann G;2006;;
Missed;whynes1999_2.pdf;Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.;David K Whynes;1999;;
Missed;wu2009_3.pdf;Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region.;Jenny Chia-Yun Wu, Ahti Anttila, Amy Ming-Fang Yen, Matti Hakama, Irma Saarenmaa, Tytti Sarkeala, Nea Malila, Anssi Auvinen, Sherry Yueh-Hsia Chiu, Tony Hsiu-Hsi Chen;2010;;
 <1998;;Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States?; Wun L.-M., Feuer E.J., Miller B.A. ;1980;;
 <1998;;Screening women aged 40-49 years: where are we today?;Comment,Editorial,Adult,Age Factors,American Cancer Society,Breast Neoplasms/diagnosis,Breast Neoplasms/mortality*,Breast Neoplasms/prevention & control*,Computer Simulation,Female,Humans,Mammography*,Mass Screening*,Middle Aged,National Institutes of Health (U.S.),Population Surveillance,Sweden,United States;1995;;
 double;;Cost-effectiveness analysis for breast cancer screening: double reading versus single plus CAD reading;Sato, Miho  Kawai, Masaaki  Nishino, Yoshikazu  Shibuya, Daisuke  Ohuchi, Noriaki  Ishibashi, Tadashi;2014;;
 double;;Cost-effectiveness of using human papillomavirus cancer screening;Vijayaraghavan, Arthi, Efrusy, Molly B., Goodman, Karyn A., Santas, Christopher C., Huh, Warner K.;2010;;
 double;;Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST);Goldwasser, Deborah L.;2017;;
 double;;Evaluation of a selective screening for colorectal carcinoma - The Taiwan Multicenter Cancer Screening (TAMCAS) project;Chen, THH  Yen, MF  Lai, MS  Koong, SL  Wang, CY  Wong, JM  Prevost, TC  Duffy, SW;1999;;
 double;;Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach.;Cl?ries R1, Mart??nez JM, Moreno V, Yasui Y, Ribes J, Borr?s JM.;2013;;
 double;;Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions;Arnold, Matthias;2017;;
 double;;SYSTEMATIC REVIEW OF MARKOV MODEL-BASED ECONOMIC EVALUATION STUDIES FOR CERVICAL CANCER SCREENING STRATEGIES: LATIN AMERICA COUNTRIES PANORAMA;Viscondi, J. Y.  Faustino, C. G.  Campolina, A. G.  De Soarez, P. C.;2017;;
 double;;The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.;Campos NG1, Jeronimo J2, Tsu V2, Castle PE3,4, Mvundura M5, Kim JJ6.;2017;;
 double;;The value of colonoscopic colorectal cancer screening of adults aged 50 to 64.;Am J Manag Care. 2015 Jul 1.21(7):e430-8.;2013;;
 double;;To screen or not to screen for breast cancer? How do modelling studies answer the question?;Koleva-Kolarova, R. G., Zhan, Z., Greuter, M. J. W., Feenstra, T. L., De Bock, G. H.;2015;;
 double;;comparative effectiveness of alternative prostate-specific antigen based prostate cancer screening strategies: model estimates of potential benefits and harms;;;;
 double;;the effect of fecal occult-blood screening on the incidence of colorectal cancer;;;;
 double;;cost-effectiveness of colonoscopy in screening for colorectal cancer;;;;
 double;;stool dna testing to screen for colorectal cancer in the medicare population: a cost-effectiveness analysis;;;;
 double;;cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population;;;;
 double;;collaborative modeling of the benefits and harms associated with different u;;;;
 double;;evaluating test strategies for colorectal cancer screening: a decision analysis for the u;;;;
 double;;a simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40 e;;;;
 double;;immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis;;;;
 double;;estimating mean sojourn time and screening sensitivity using data on time since previous screening;;;;
 For request;;A Markov model for optimal intervals in prostate cancer screening programs in the era of individual baseline PSA values;Kobayashi, T, Goto-Watanabe, R, Ito, K, Mitsumori, K;2005;;
 For request;;Lifetime costs of colon and rectal cancer management in Canada;Maroun J., Ng E., Berthelot J.-M., Le Petit C., Dahrouge S., Flanagan W.M., Walker H., Evans W.K.;2003;;
 For request;;Potential impact of population-based colorectal cancer screening in Canada.;Flanagan WM1, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E.;2003;;
 For request;;Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.;;2009;;
 For request;;Simulation modeling of lung cancer screening cost-effectiveness analysis;Wan, W.;2015;;
 For request;;The Cancer Risk Management Model: A Tool to Inform Canadian Policymakers Implementing Low-Dose CT Screening for Lung Cancer;Evans, William K., Gofffin, John, Flanagan, William, Miller, Anthony, Fitzgerald, Natalie, Memon, Saima, Fung, Sharon, Wolfson, Michael;2015;;
 For request;;The Economic Evaluation of Lung Cancer Screening Using a System Model,; Koinuma N. ;2003;;
 For request;;The economic evaluation of screening for colorectal cancer: Case of Iran.;Clin Lab. 2013.59(5-6):667-74.;2011;;
 For request;;USE OF RELATIVE RISK RATIOS TO PRESENT UNCERTAINTY IN MICROSIMULATION MODELS WITH MULTIPLE COMPARATORS: AN APPLICATION TO BREAST CANCER SCREENING STRATEGIES;Shih, Y. T.  Doug, W.  Xu, Y.  Yu, S.;2017;;
 For request;;Using simulation to assess the effect of cervical cancer screening policies in Taiwan,; Hwang L.-L. ;2007;;
 For request;;Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries.;Peterse EFP1, Meester RGS2, Gini A3, Doubeni CA4, Anderson DS5, Berger FG6, Zauber AG7, Lansdorp-Vogelaar I8.;2017;;
 For request;;What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.;;2011;;
 For request;;flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a community-based project;;;;
 For request;;evaluation of a selective screening for colorectal carcinoma: the taiwan multicenter cancer screening (tamcas) project;;;;
 No trace;;economic evaluation and modelling study prepared by ims health pty ltd australia for the australian government department of health and ageing;;;;
 Not a paper;;ACCELERATING DECISION-MAKING WITH MICROSIMULATION: THE ADOPTION OF EVIDENCE IN CERVICAL CANCER SCREENING;Fitzgerald, Natalie R., Asakawa, Keiko, Coldman, Andrew, Evans, William K., Flanagan, William M., Gribble, Steve, Lockwood, Gina, Memon, Saima, Miller, Anthony B., Nadeau, Claude, Popadiuk, Cathy, Wolfson, Michael C.;2014;;
 Not a paper;;BREAST CANCER SCREENING PROGRAM IN THE BASQUE COUNTRY: COSTS AND HEALTH BENEFITS ASESSMENT THROUGH DISCRETE EVENT SIMULATION;Arrospide, A., Mar, J., Comas, M., Rue, M., Larranaga, N., Acaiturri, T., Sarriugarte, G.;2013;;
 Not a paper;;Colorectal Cancer Screening Based on Age and Gender A Cost-Effectiveness Analysis;Wong, Martin C. S., Ching, Jessica Y. L., Chan, Victor C. W., Lam, Thomas Y. T., Luk, Arthur K. C., Wong, Sunny H., Ng, Siew C., Ng, Simon S. M., Wu, Justin C. Y., Chan, Francis K. L., Sung, Joseph J. Y.;2016;;
 Not a paper;;CONSTRUCTION OF SIMULATION TECHNIQUES FOR DEVELOPMENT OF OPTIMAL CERVICAL CANCER SCREENING STRATEGIES: EXPERIENCE OF UKRAINE;Soloviov, S., Artemchuk, H., Kovalyuk, O., Dzyublyk, I, Dutchak, I;2015;;
 Not a paper;;Controlling cervical cancer.;;;;
 Not a paper;;Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing;Wong, Carlos K. H.  Lam, Cindy L. K.  Wan, Y. F.  Fong, Daniel Y. T.;2015;;
 Not a paper;;Cost-effectiveness studies fan colonoscopy debate.;;;;
 Not a paper;;ESTIMATING THE RESOURCES NEEDED TO IMPLEMENT A POPULATION-BASED COLORECTAL CANCER SCREENING PROGRAM THROUGH DISCRETE EVENT SIMULATION;Comas, M., Arrospide, A., Mendivil, J., Mar, J., Hernandez, C., Buron, A., Andreu, M., Castells, X.;2012;;
 Not a paper;;EXPLORING THE HEALTH OUTCOMES OF VARIOUS PAN-CANADIAN CERVICAL CANCER SCREENING PROGRAMS USING MICROSIMULATION MODELING.;Lacombe, J., Gauvreau, C. L., Memon, S., Popadiuk, C., Flanagan, W. M., Nadeau, C., Coldman, A. J., Wolfson, M. C., Miller, A. B.;2016;;
 Not a paper;;Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.;de Gelder R1, Draisma G, Heijnsdijk EA, de Koning HJ.;2011;;
 Not a paper;;PREDICTING FUTURE NEED OF RESOURCES FOR ADENOMA SURVEILLANCE FROM A POPULATION-BASED COLORECTAL CANCER SCREENING PROGRAM THROUGH DISCRETE EVENT SIMULATION;Comas, M., Andreu, M., Guerrero-Luduena, R. E., Bessa, X., Balague, F., Castells, X.;2015;;
 Not a paper;;REVISITING THE SIMULATION EVIDENCE FOR THE INCREMENTAL COST-EFFECTIVENESS OF BREAST CANCER SCREENING OF AVERAGE-RISK WOMEN;O'Mahony, J. F.;2015;;
 Not a paper;;department of health and human services publication no;;;;
 Not a paper;;effect of screening and adjuvant therapy on mortality from breast cancer;;;;
 Not a paper;;economic  models  of  colorectal  cancer  screening:  a workshop;;;;
 Not a paper;;national evaluation of breast cancer screening in the netherlands 1990â“2011/2012;;;;
 Not a paper;;health economics review of bowel cancer screening in australia;;;;
 Not a paper;;colorectal cancer screening for the natural population of beijing with sequential fecal occult blood test: a multicenter study;;;;
 Not a paper;;quantitative methods for the evaluation of cancer screening;;;;
 Not english;;Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging;de Freitas Peregrino, Antonio Augusto  de Mello Vianna, Cid Manso  Veloso de Almeida, Carlos Eduardo  Gonzales, Gabriela Bittencourt  Ferreira Machado, Samara Cristina  Costa e Silva, Frances Valeria  da Silva Rodrigues, Marcus Paulo;2012;;
 Not english;;Colorectal cancer screening: advice from the Health Council of the Netherlands].;van Veen W1, Mali WP.;2009;;
 Not english;;Cost-effectiveness analysis of mammography screening for Chinese women;Zhang F., Luo L.M., Bao X.D., Chen B.-J.;2012;;
 Not english;;Cost-effectiveness of an organized breast cancer screening program in Southern Brazil;Ribeiro, Rodrigo Antonini  Caleffi, Maira  Polanczyk, Carisi Anne;2013;;
 Not english;;generalized cost-effectiveness of preventive interventions against cervical cancer in mexican women: results of a markov model from the public sector perspective;;;;
 Not english;;effectiveness of screening colonoscopy in a community-based study;;;;
 Not relevant;;Screening effect of breast cancer incidence among the population of Bryansk and Orel oblasts of the Russian Federation,; Kashcheev V.V., Chekin S.Yu., Maksioutov M.A., Tumanov K.A., Korelo A.M., Kochergina E.V., Vlasov O.K., Shchukina N.V. ;2016;;
 Not relevant;;prevention and treatment of cervical cancer a global and regional generalized cost-effectiveness analysis;;;;
 Systematic review;;Cost-effectiveness analysis of strategies for screening prostatic cancer.;;;;
 Systematic review;;Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.;Marra F1, Cloutier K, Oteng B, Marra C, Ogilvie G.;2009;;
